Tumour heterogeneity and cancer cell plasticity.
- Authors
- Meacham, Corbin E; Morrison, Sean J
- Year
- 2013
- Journal
- Nature
- PMID
- 24048065
- DOI
- 10.1038/nature12624
- PMCID
- PMC4521623
Phenotypic and functional heterogeneity arise among cancer cells within the same tumour as a consequence of genetic change, environmental differences and reversible changes in cell properties. Some cancers also contain a hierarchy in which tumorigenic cancer stem cells differentiate into non-tumorigenic progeny. However, it remains unclear what fraction of cancers follow the stem-cell model and what clinical behaviours the model explains. Studies using lineage tracing and deep sequencing could have implications for the cancer stem-cell model and may help to determine the extent to which it accounts for therapy resistance and disease progression.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Statistical modeling for sensitive detection of low-frequency single nucleotide variants. | 2016 | 27556804 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A guide to transcriptomic deconvolution in cancer. | Dai Y et al. | β | 2026 | β |
| A High-Density Microchamber Array for the Analysis of Extracellular Vesicles Derived from Single Cells under Drug Treatment. | StΓΆcklin LR et al. | β | 2026 | β |
| A hormetic transcriptional program coregulates invasion, proliferation and dormancy to define metastatic potential. | JimΓ©nez-CastaΓ±o R et al. | β | 2026 | β |
| ALDH1A inhibitors: Research advances in cancer therapeutics. | Zhao X et al. | β | 2026 | β |
| Cancer stem cell heterogeneityβinspired therapeutics for enhancing tumor treatment outcomes (Review). | Xu H et al. | β | 2026 | β |
| CanSig Benchmarks Methods for Reproducible Cancer Cell State Discovery from Single-Cell Transcriptomic Data. | Barkmann F et al. | β | 2026 | β |
| CEBPB-Regulated Gastric Cell Plasticity Promotes Liver Metastasis of Gastric Cancer. | Zuo Z et al. | β | 2026 | β |
| CFMF: A Clustering-Free Cell Marker Finder for Single-Cell Transcriptomic Data. | Yin S et al. | β | 2026 | β |
| Chimeric CD3ΞΆ chains containing CD28 signalling motifs enhance antigen-specific IL-2 production and expansion of human TCR-engineered T cells <i>in vitro</i>. | Burgess SJ et al. | β | 2026 | β |
| Endoplasmic reticulum stress in disease pathogenesis: its implications for therapy. | Wei S et al. | β | 2026 | β |
| Engineered Extracellular Vesicles for Cancer Stem Cell Theranostics: Recent Advances and Future Perspectives. | Abdullah M et al. | β | 2026 | β |
| Enhancing cell subpopulation discovery in cancer by integrating single-cell transcriptome and expressed variants. | Wang T et al. | β | 2026 | β |
| HSFSurv: A hybrid supervision framework at individual and feature levels for multimodal cancer survival analysis. | Fu B et al. | β | 2026 | β |
| Interferons as therapeutic orchestrators of cancer stem cell plasticity and therapy response. | Kasat D et al. | β | 2026 | β |
| Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML. | Karigane D et al. | β | 2026 | β |
| Label-free fluorescent quantification of L858R single-nucleotide variant in EGFR gene in single-tube magnetic purification system. | Lai KP et al. | β | 2026 | β |
| Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment Resistance. | Bakhshinyan D et al. | β | 2026 | β |
| Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs. | Starenko D et al. | β | 2026 | β |
| Mechanism of cancer-associated fibroblast-driven thyroid cancer dedifferentiation via the ZFP57-PKM2 axis-mediated lactate secretion and therapeutic intervention with resveratrolβ. | Ji X et al. | β | 2026 | β |
| Microenvironment-Guided Evolution of ssDNA-SWCNT Probes for Selective Recognition of Aggressive Prostate Cancer Phenotypes. | Lee D et al. | β | 2026 | β |
| Molecular analysis of tumor recurrence using established cancer stem cell-line and drug discovery. | Nakano K et al. | β | 2026 | β |
| Overcoming Resistance and Relapse in CAR-T and CAR-NK Cell Therapies: From Bench to Bedside. | Wang Y et al. | β | 2026 | β |
| Phenotyping by Molecular Mobility: Low-Affinity Reversible Probes Enable Characterizing and Classifying Cells Populations by Single-Molecule Imaging. | Riera R et al. | β | 2026 | β |
| Polyploid cisplatin-resistant cancer cells have altered nuclear organization and epigenomic status. | Gonye AL et al. | β | 2026 | β |
| Single Cell Quantification of Let-7a with an Electrophoresis-Assisted Tandem Signal Amplification Strategy based on Intracellular Catalytic Hairpin Assembly-Branched Hybridization Chain Reaction-MNAzyme. | Chen Y et al. | β | 2026 | β |
| SMARCA4 regulates SMARCAD1 expression for toleration of replication stress in non-small cell lung cancer. | Sawangsri P et al. | β | 2026 | β |
| Stimuli-activatable protein degraders for targeted cancer therapy: from prodrug design to nanoplatform applications. | Jiang X et al. | β | 2026 | β |
| Synergistic anticancer effects of tamoxifen in combination with fisetin and chrysin on breast cancer cells: insights into viability, migration, and apoptosis. | Karami-Dehkordi N et al. | β | 2026 | β |
| Two paired HPV-59 cervical cancer cell lines with distinct chemoradioresistant phenotypes. | Tatarnikova I et al. | β | 2026 | β |
| When Clocks Go Rogue: Circadian Rhythms and the Rise of Cancer. | Robinson AS et al. | β | 2026 | β |
| 3D-printed plugs enhance cell usage efficiency for single-cell migration and neuron axon guidance assays. | Cheng J et al. | β | 2025 | β |
| A Bifunctional Lysosome-Targeting Chimera Nanoplatform for Tumor-Selective Protein Degradation and Enhanced Cancer Immunotherapy. | Xing Y et al. | β | 2025 | β |
| Actin dysregulation induces neuroendocrine plasticity and immune evasion: a vulnerability of small cell lung cancer. | Seo Y et al. | β | 2025 | β |
| Adenine nucleotide translocase 2 silencing promotes metabolic reprogramming in P19 embryonal carcinoma stem cells. | Oliveira GL et al. | β | 2025 | β |
| A DNA Nanomachine Modulates the Stemness-Associated Signaling Pathways for Overcoming Chemoresistance by Temporally Programming Drug Release. | Chen J et al. | β | 2025 | β |
| An FGFR-p53 developmental signaling axis drives salivary cancer progression. | Musicant AM et al. | β | 2025 | β |
| An old spice with new tricks: Curcumin targets adenoma and colorectal cancer stem-like cells associated with poor survival outcomes. | Khan S et al. | β | 2025 | β |
| A patient-derived organoid model captures fetal-like plasticity in colorectal cancer. | Xiong L et al. | β | 2025 | β |
| Application of an Integrated Single-Cell and Three-Dimensional Spheroid Culture Platform for Investigating Drug Resistance Heterogeneity and Epithelial-Mesenchymal Transition (EMT) in Lung Cancer Subclones. | Chen SH et al. | β | 2025 | β |
| A small-molecule compound cocktail for tumor reprogramming therapy for breast cancer. | Wang Z et al. | β | 2025 | β |
| ATP6V1D drives hepatocellular carcinoma stemness and progression via both lysosome acidification-dependent and -independent mechanisms. | Xu Z et al. | β | 2025 | β |
| Bayesian Inference of Phenotypic Plasticity of Cancer Cells Based on Dynamic Model for Temporal Cell Proportion Data. | Chen S et al. | β | 2025 | β |
| Biology of stem cell paradox: a double-edged sword-implications for cancer therapy. | Mengistu BA et al. | β | 2025 | β |
| Cancer-on-a-chip for precision cancer medicine. | Liu L et al. | β | 2025 | β |
| Cancer Stem Cells Connecting to Immunotherapy: Key Insights, Challenges, and Potential Treatment Opportunities. | Mathan SV et al. | β | 2025 | β |
| Cancer stem-like cells stay in a plastic state ready for tumor evolution. | Xu J et al. | β | 2025 | β |
| Cellular Systems for Colorectal Stem Cancer Cell Research. | Grigoreva TA et al. | β | 2025 | β |
| Characterization of stem cell landscape and identification of stemness-related gene ENY2 in colorectal cancer by intergrated transcriptomic analysis. | Hao W et al. | β | 2025 | β |
| Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in breast cancer. | Yang X et al. | β | 2025 | β |
| CircRNA-mTOR Promotes Hepatocellular Carcinoma Progression and Lenvatinib Resistance Through the PSIP1/c-Myc Axis. | Tang Y et al. | β | 2025 | β |
| Clinical implications of epithelial-to-mesenchymal transition in cancers which potentially spread to peritoneum. | Carbone L et al. | β | 2025 | β |
| CluVar: clustering of variants using autoencoder for inferring cancer subclones from single cell RNA sequencing data. | Kim CW et al. | β | 2025 | β |
| Co-delivery of TRAIL DNA and salinomycin for cancer therapy <i>via</i> enhanced apoptosis and cancer stemness inhibition. | Zhong H et al. | β | 2025 | β |
| Comprehensive Analysis of scRNA-Seq and Bulk RNA-Seq Identified TIMP1 as a Prognostic Marker in Colorectal Cancer. | Luo QW et al. | β | 2025 | β |
| Comprehensive characterization of the molecular feature of T cells in laryngeal cancer: evidence from integrated single-cell and bulk RNA sequencing data using multiple machine learning approaches. | Cui J et al. | β | 2025 | β |
| Confronting Melanoma Radioresistance: Mechanisms and Therapeutic Strategies. | Gorodetska I et al. | β | 2025 | β |
| Construction of a prognostic model for gastric cancer based on immune infiltration and microenvironment, and exploration of MEF2C gene function. | Wang SY et al. | β | 2025 | β |
| Cyclodextrin-Based Metal-Organic Framework as an Application Platform for Bioactive Ruthenium(III) Complexes. | Marzabad MA et al. | β | 2025 | β |
| Deciphering Breast Tumor Heterogeneity Through Patient-Derived Organoids and Circulating Tumor Cells. | Policastro B et al. | β | 2025 | β |
| Deciphering normal and cancer stem cell niches by spatial transcriptomics: opportunities and challenges. | Sarkar H et al. | β | 2025 | β |
| Deciphering precursor cell dynamics in esophageal preneoplasia via genetic barcoding and single-cell transcriptomics. | Jang J et al. | β | 2025 | β |
| Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy. | Pienta KJ et al. | β | 2025 | β |
| Divergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in Castration-Resistant Prostate Cancer. | Hosseini N et al. | β | 2025 | β |
| Endothelial transdifferentiation of glioma stem cells: a literature review. | Buruiana A et al. | β | 2025 | β |
| Evaluating Breast Cancer Intravoxel Incoherent Motion MRI Biomarkers across Software Platforms. | Sigmund EE et al. | β | 2025 | β |
| Exosome-based approaches in cancer along with unlocking new insights into regeneration of cancer-prone tissues. | Safaei M et al. | β | 2025 | β |
| Exosomes as a Therapeutic Strategy in Cancer: Potential Roles as Drug Carriers and Immune Modulators. | Abedi A et al. | β | 2025 | β |
| Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines. | Li Y et al. | β | 2025 | β |
| Free fatty acid-induced DDX3 inhibits autophagy via miR-141 upregulation in diet-induced MASLD mice model system. | Hossain MM et al. | β | 2025 | β |
| From morphology to single-cell molecules: high-resolution 3D histology in biomedicine. | Xu X et al. | β | 2025 | β |
| GLA-Synergy: An Interpretable Global-Local Adaptive Framework for Drug Synergy Prediction in Cancer Treatment. | Deng L et al. | β | 2025 | β |
| Glioma cells achieve malignant progression by fusion with macrophages to gain high SLC7A5 expression. | Hu Y et al. | β | 2025 | β |
| Glycosaminoglycan modification of NRP1 exon 4-skipping variant drives colorectal cancer metastasis via endosomal-exosomal trafficking. | Gu Y et al. | β | 2025 | β |
| Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies. | Basu R et al. | β | 2025 | β |
| HCT116 cell line heterogeneity: A useful tool for preclinical research. | Grigoreva TA et al. | β | 2025 | β |
| Histone Methyltransferase SETD1B Maintains Cancer Stem Cell Niche by Regulating the Crosstalk between CD24 and Surface Adhesion Molecules in Hepatocellular Carcinoma. | Gao Y et al. | β | 2025 | β |
| Hybrid Platinum(IV)-Naproxen Nanostructured Drugs Reprogram Melanoma Cells and Overpower Cisplatin. | Komazec T et al. | β | 2025 | β |
| Hydroxycitrate-loaded exosomes demonstrate enhanced therapeutic efficacy against lung adenocarcinoma by inhibiting the metabolic enzyme ATP citrate lyase. | Phutela K et al. | β | 2025 | β |
| Identification of Phenotypically Distinct Cancer Stem Cell Subpopulations in Oral Squamous Cell Carcinoma. | Osman TA et al. | β | 2025 | β |
| Image-based inference of tumor cell trajectories enables large-scale cancer progression analysis. | Liu Y et al. | β | 2025 | β |
| Induction of a metabolic switch from glucose to ketone metabolism programs ketogenic diet-induced therapeutic vulnerability in lung cancer. | Wu Z et al. | β | 2025 | β |
| Inferring Birth Versus Death Dynamics for Ecological Interactions in Stochastic Heterogeneous Populations. | Beckman E et al. | β | 2025 | β |
| Integrating Hypoxia Signatures from scRNA-seq and Bulk Transcriptomes for Prognosis Prediction and Precision Therapy in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. | Yu K et al. | β | 2025 | β |
| Interplay Between Traditional and Scientific Knowledge: Phytoconstituents and Their Roles in Lung and Colorectal Cancer Signaling Pathways. | Imtiaz I et al. | β | 2025 | β |
| Investigation of the clinical significance of the expression of immunohistochemical biomarkers Enhancer of zeste homolog 2 and Forkhead box M1 in localized prostate cancer tissue: A Greek retrospective study. | Koubardas S et al. | β | 2025 | β |
| Is There Any Difference in Stem Cell Population between Type I and Type II Endometrial Cancer? A Pilot Study. | Muthuraman N et al. | β | 2025 | β |
| Long-term and short-term cardiovascular disease mortality among patients of 21 non-metastatic cancers. | Guan T et al. | β | 2025 | β |
| Loss of cadherin 17 downregulates LGR5 expression, stem cell properties and drug resistance in metastatic colorectal cancer cells. | BartolomΓ© RA et al. | β | 2025 | β |
| <i>Eugenia uniflora</i> L.: Analysis of Chemical Profile and Cytotoxic Action on Tumor (HeLa) and Non-Tumor Cells (NIH/3T3). | Pescinelli LMR et al. | β | 2025 | β |
| Mechanistic insights into resistance mechanisms to T cell engagers. | Cao L et al. | β | 2025 | β |
| Metabolic reprogramming and functional crosstalk within the tumor microenvironment (TME) and A Multi-omics anticancer approach. | Mir R et al. | β | 2025 | β |
| Microalgae: A Treasure Trove of Anticancer Nutraceuticals and Promising Therapeutic Mechanisms. | Masoumi S et al. | β | 2025 | β |
| MMP9 shapes cell mechanics to enable collective invasion in cancer. | Asadullah et al. | β | 2025 | β |
| Multi-scale cancer driver gene prediction by flexible data selection and network topology guidance. | Liu J et al. | β | 2025 | β |
| Natural Metabolites as Modulators of Sensing and Signaling Mechanisms: Unlocking Anti-Ovarian Cancer Potential. | Verma M et al. | β | 2025 | β |
| Navigating the Molecular Signaling: Deciphering Cancer Stem Cell Self-Renewal Pathways. | Hoseinian SN et al. | β | 2025 | β |
| Optimization method for determining vertices in lattice radiotherapy. | Ma P et al. | β | 2025 | β |
| Optimizing CAR T cell therapy for solid tumours: a clinical perspective. | Li J et al. | β | 2025 | β |
| Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance. | Coppo R et al. | β | 2025 | β |
| Pharmacological Inhibition of cFLIP Targets Breast Cancer Stem Cells. | French R et al. | β | 2025 | β |
| Pioneer in Molecular Biology: Conformational Ensembles in Molecular Recognition, Allostery, and Cell Function. | Nussinov R | β | 2025 | β |
| Potentiation of Tumor Hallmarks by the Loss of GULO, a Vitamin C Biosynthesis Gene in Humans. | Sekar G et al. | β | 2025 | β |
| Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells. | DrΓ‘pela S et al. | β | 2025 | β |
| Prospective Isolation According to Melanin Pigment Content of Melanoma Cells With Heterogeneous Potentials for Disease Propagation. | Fedele C et al. | β | 2025 | β |
| ProteogenomicΒ characterisation of primary oral cancer unveils extracellular matrix remodelling and immunosuppressive microenvironment linked to lymph node metastasis. | Liu Y et al. | β | 2025 | β |
| Recent Developments in the Synthesis of Benzothiazoles and their Anti-cancer Mechanistic Discoveries. | Zaghary WA et al. | β | 2025 | β |
| Role of CD28<sup>+</sup> PD-1<sup>+</sup> Tc cells in immune response and prognosis prediction in hepatocellular carcinoma. | Yang W et al. | β | 2025 | β |
| SCANER: robust and sensitive identification of malignant cells from the scRNA-seq profiled tumor ecosystem. | Xia P et al. | β | 2025 | β |
| Selectively expressed RNA molecules as a versatile tool for functionalized cell targeting. | Rastfeld F et al. | β | 2025 | β |
| Sensitizing ferroptotic and apoptotic cancer therapy via tailored micelles-mediated coenzyme and ATP depletion under hypoxia. | Gao M et al. | β | 2025 | β |
| Sex differences in the molecular profile of adult diffuse glioma are shaped by IDH status and tumor microenvironment. | Huang Y et al. | β | 2025 | β |
| Shape matters: inferring the motility of confluent cells from static images. | Braat QJS et al. | β | 2025 | β |
| Single-cell transcriptomics analysis reveals that the tumor-infiltrating B cells determine the indolent fate of papillary thyroid carcinoma. | Li C et al. | β | 2025 | β |
| siRNA-based therapy for overcoming drug resistance in human solid tumours; molecular and immunological approaches. | Pallathadka H et al. | β | 2025 | β |
| SNORA74A Drives Self-Renewal of Liver Cancer Stem Cells and Hepatocarcinogenesis Through Activation of Notch3 Signaling. | Zhou Z et al. | β | 2025 | β |
| Softness or Stiffness What Contributes to Cancer and Cancer Metastasis? | Mierke CT | β | 2025 | β |
| Spatial metabolomics atlas in the progression of oral squamous cell carcinoma. | Zhao H et al. | β | 2025 | β |
| Spatial proteomics and transcriptomics characterization of tissue and multiple cancer types including decalcified marrow. | Yeung CC et al. | β | 2025 | β |
| Special Issue "Molecular Research in Breast Cancer: Pathophysiology and Treatment". | Frangou C | β | 2025 | β |
| Stemness regulation in prostate cancer: prostate cancer stem cells and targeted therapy. | Liang H et al. | β | 2025 | β |
| Subtle alteration in transcriptional memory governs the lineage-level cell cycle duration heterogeneities of mammalian cells. | Charan K et al. | β | 2025 | β |
| Supramolecular Combination Chemotherapy: Directly Inducing Immunogenic Cell Death To Inhibit Tumor Metastasis via Host-Guest Interactions. | Liu Q et al. | β | 2025 | β |
| Synthetic NKG2D receptor (SNR) armored CAR-T cells overcome antigen heterogeneity of solid tumor. | Sun M et al. | β | 2025 | β |
| Systems Biology-Based Drug Repositioning Identifies Extracellular Matrix Module as a Therapeutic Target in Lung Squamous Cell Carcinoma. | Yang B et al. | β | 2025 | β |
| Targeting the tumour cell surface in advanced prostate cancer. | Boixareu C et al. | β | 2025 | β |
| TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma. | Wang W et al. | β | 2025 | β |
| Texture analysis can predict response to etoposide-doxorubicin-cisplatin in patients with adrenocortical carcinoma. | CrimΓ¬ F et al. | β | 2025 | β |
| The crosstalk within tumor microenvironment and exosomes in pancreatic cancer. | Otieno MO et al. | β | 2025 | β |
| The immunomodulatory role of tumor-initiating cells in digestive system tumors: from mechanisms to therapy. | Zhang ZY et al. | β | 2025 | β |
| The key role of cellular plasticity in the development of colorectal cancer. | Lou L et al. | β | 2025 | β |
| The multilayered transcriptional architecture of glioblastoma ecosystems. | Nomura M et al. | β | 2025 | β |
| The plasticity of cancer-associated fibroblasts. | Xia Z et al. | β | 2025 | β |
| The present and future of the Cancer Dependency Map. | Arafeh R et al. | β | 2025 | β |
| Therapeutic targets in the Wnt signaling pathway: Treating cancer with specificity. | Zhang J et al. | β | 2025 | β |
| The role of cancer stem cells in the progression of colorectal cancer and the tumor microenvironment: new perspectives from single-cell RNA sequencing and spatial transcriptomics analyses. | Wu Y et al. | β | 2025 | β |
| The translatome of glioblastoma. | Cornelissen FMG et al. | β | 2025 | β |
| Transforming microfluidics for single-cell analysis with robotics and artificial intelligence. | Cheng J et al. | β | 2025 | β |
| Triplet therapy for metastatic castration-sensitive prostate cancer: Rationale and clinical evidence. | Suzuki H et al. | β | 2025 | β |
| Tumor-Specific Protein Induced in Situ Self-Assembly of Peptide Drugs for Synergistic Mitochondria Disruption. | Hao Y et al. | β | 2025 | β |
| Tumor subtype classification tool for HPV-associated head and neck cancers. | Li S et al. | β | 2025 | β |
| Ultrasound-enhanced gene transfection: vectors, methods, and biomedical applications. | Wu J et al. | β | 2025 | β |
| Unlocking artificial intelligence, machine learning and deep learning to combat therapeutic resistance in metastatic castration-resistant prostate cancer: a comprehensive review. | Ejaz ZH et al. | β | 2025 | β |
| A Bayesian framework to study tumor subclone-specific expression by combining bulk DNA and single-cell RNA sequencing data. | Qiao Y et al. | β | 2024 | β |
| A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases. | Jeising S et al. | β | 2024 | β |
| A computational approach for analysis of intratumoral heterogeneity and standardized uptake value in PET/CT images1. | Alshamrani K et al. | β | 2024 | β |
| ACSL3 regulates breast cancer progression <i>via</i> lipid metabolism reprogramming and the YES1/YAP axis. | Tan S et al. | β | 2024 | β |
| Advances in Single-Cell Techniques for Linking Phenotypes to Genotypes. | Chen HC et al. | β | 2024 | β |
| A "Ferroptosis-Amplifier" Hydrogel for Eliminating Refractory Cancer Stem Cells Post-lumpectomy. | Zhu Y et al. | β | 2024 | β |
| A Hitchhiker's guide to high-dimensional tissue imaging with multiplexed ion beam imaging. | Yeo YY et al. | β | 2024 | β |
| ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy. | Lavudi K et al. | β | 2024 | β |
| Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis. | Horgan D et al. | β | 2024 | β |
| A live single-cell reporter system reveals drug-induced plasticity of a cancer stem cell-like population in cholangiocarcinoma. | Kongtanawanich K et al. | β | 2024 | β |
| A logic-activated nanoswitch for killing cancer cells according to assessment of drug-resistance. | Zhang L et al. | β | 2024 | β |
| A Multi-Omics Analysis of an Exhausted T Cells' Molecular Signature in Pan-Cancer. | Rigopoulos C et al. | β | 2024 | β |
| Androgens in cervical cancer: Their role in epidemiology and biology. | Gu Y et al. | β | 2024 | β |
| An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images. | Javed S et al. | β | 2024 | β |
| An isoform-resolution transcriptomic atlas of colorectal cancer from long-read single-cell sequencing. | Li Z et al. | β | 2024 | β |
| A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells. | Fonseca P et al. | β | 2024 | β |
| A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy. | Gao J et al. | β | 2024 | β |
| A Versatile Microfluidic Device System that Lacks a Synthetic Extracellular Matrix Recapitulates the Blood-Brain Barrier and Dynamic Tumor Cell Interaction. | SantillΓ‘n-Cortez D et al. | β | 2024 | β |
| BATF2 inhibits the stem cell-like properties and chemoresistance of gastric cancer cells through PTEN/AKT/Ξ²-catenin pathway. | Cao L et al. | β | 2024 | β |
| Bayesian Landmark-based Shape Analysis of Tumor Pathology Images. | Zhang C et al. | β | 2024 | β |
| Biomimetic Hydrogel Strategies for Cancer Therapy. | Alshehri AM et al. | β | 2024 | β |
| Breaking-Down Tumoral Physical Barrier by Remotely Unwrapping Metal-Polyphenol-Packaged Hyaluronidase for Optimizing Photothermal/Photodynamic Therapy-Induced Immune Response. | Sun Q et al. | β | 2024 | β |
| Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance. | Bhat GR et al. | β | 2024 | β |
| Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges. | Acharya SK et al. | β | 2024 | β |
| Cancer stem cells release interleukin-33 within large oncosomes to promote immunosuppressive differentiation of macrophage precursors. | Erickson HL et al. | β | 2024 | β |
| CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle. | Zhou HY et al. | β | 2024 | β |
| CD146, a therapeutic target involved in cell plasticity. | Wu Z et al. | β | 2024 | β |
| Cell type specific long non-coding RNA targets identified by integrative analysis of single-cell and bulk colorectal cancer transcriptomes. | Mihaljevic A et al. | β | 2024 | β |
| Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data. | Liu W et al. | β | 2024 | β |
| CRACD loss induces neuroendocrine cell plasticity of lung adenocarcinoma. | Kim B et al. | β | 2024 | β |
| CRISPR screens in 3D tumourspheres identified miR-4787-3p as a transcriptional start site miRNA essential for breast tumour-initiating cell growth. | Stiff T et al. | β | 2024 | β |
| Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era. | Xiong X et al. | β | 2024 | β |
| Dedifferentiated Leiomyosarcoma of the Uterine Corpus with Heterologous Component: Clinicopathological Analysis of Five Consecutive Cases from a Single Institution and Comprehensive Literature Review. | Kim S et al. | β | 2024 | β |
| Differential Abundance of DNA Damage Sensors and Innate Immune Signaling Proteins in Inositol Polyphosphate 4-Phosphatase Type II-Negative Triple-Negative Breast Cancer Classified by Immunotype. | Heinemann FS et al. | β | 2024 | β |
| Diversity of Intercellular Communication Modes: A Cancer Biology Perspective. | Ebrahim T et al. | β | 2024 | β |
| Double-faced CX3CL1 enhances lymphangiogenesis-dependent metastasis in an aggressive subclone of oral squamous cell carcinoma. | Eain HS et al. | β | 2024 | β |
| Double-Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of Tumors. | Li Z et al. | β | 2024 | β |
| Dynamics of liver cancer cellular taxa revealed through single-cell RNA sequencing: Advances and challenges. | Li W et al. | β | 2024 | β |
| Effect of PAWI-2 on pancreatic cancer stem cell tumors. | Cashman JR et al. | β | 2024 | β |
| Electrochemical Biosensors for Cancer Diagnosis: Multitarget Analysis to Present Molecular Characteristics of Tumor Heterogeneity. | Cao Y et al. | β | 2024 | β |
| Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing. | Zhao F et al. | β | 2024 | β |
| EpiCHAOS: a metric to quantify epigenomic heterogeneity in single-cell data. | Kelly K et al. | β | 2024 | β |
| Epigenetic control of cell signalling in cancer stem cells. | Joshi G et al. | β | 2024 | β |
| Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer. | Schniewind I et al. | β | 2024 | β |
| Epigenome editing in cancer: Advances and challenges for potential therapeutic options. | Lee SW et al. | β | 2024 | β |
| Exosome-sheathed porous silica nanoparticle-mediated co-delivery of 3,3'-diindolylmethane and doxorubicin attenuates cancer stem cell-driven EMT in triple negative breast cancer. | Sarkar R et al. | β | 2024 | β |
| Exploiting transcription factors to target EMT and cancer stem cells for tumor modulation and therapy. | Khan AQ et al. | β | 2024 | β |
| Extracellular matrix shapes cancer stem cell behavior in breast cancer: a mini review. | Li L et al. | β | 2024 | β |
| FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway. | Wang L et al. | β | 2024 | β |
| From Radiation Genetics, Mutagenesis, Gap Junctions, Epigenetics, Stem Cells and an Integration of Radiation and Chemical Carcinogenesis. | Trosko JE | β | 2024 | β |
| Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma. | Tarantino G et al. | β | 2024 | β |
| Histology-Based Radiomics for [<sup>18</sup>F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer. | Smeets EMM et al. | β | 2024 | β |
| Identification and characterization of TM4SF1<sup>+</sup> tumor self-seeded cells. | Yang H et al. | β | 2024 | β |
| Identification of a novel cancer-associated fibroblasts gene signature based on bioinformatics analysis to predict prognosis and therapeutic responses in breast cancer. | Song J et al. | β | 2024 | β |
| IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. | Zhang K et al. | β | 2024 | β |
| Impact of prolactin treatment on enhancing the cellular responses of MCF7 breast cancer cells to tamoxifen treatment. | Shams A | β | 2024 | β |
| Implementation of antibody-drug conjugates in HER2-positive solid cancers: Recent advances and future directions. | Yu J et al. | β | 2024 | β |
| Insights into the role of the N6-methyladenosine reader IGF2BP3 in the progression of oral squamous cell carcinoma and its connection to cell-cycle control. | Song D et al. | β | 2024 | β |
| Integrating bulk and single-cell data to predict the prognosis and identify the immune landscape in HNSCC. | Yang C et al. | β | 2024 | β |
| Iron metabolism: backfire of cancer cell stemness and therapeutic modalities. | Yu R et al. | β | 2024 | β |
| Lactate drives the ESM1-SCD1 axis to inhibit the antitumor CD8<sup>+</sup> T-cell response by activating the Wnt/Ξ²-catenin pathway in ovarian cancer cells and inducing cisplatin resistance. | Fan Z et al. | β | 2024 | β |
| Lectin-modified drug delivery systems - Recent applications in the oncology field. | Silva MLS | β | 2024 | β |
| Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far? | Vishwa R et al. | β | 2024 | β |
| Localized FDG loss in lung cancer lesions. | Parodi D et al. | β | 2024 | β |
| Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response. | Fischer KD et al. | β | 2024 | β |
| Lysosome-Related Genes and RNF19B as Prognostic Markers for Survival and Immunotherapy Efficacy in Hepatocellular Carcinoma. | Li J et al. | β | 2024 | β |
| Manipulating Redox Homeostasis of Cancer Stem Cells Overcome Chemotherapeutic Resistance through Photoactivatable Biomimetic Nanodiscs. | Wang B et al. | β | 2024 | β |
| Metabolic Heterogeneity and Potential Immunotherapeutic Responses Revealed by Single-Cell Transcriptomics of Breast Cancer. | Tang S et al. | β | 2024 | β |
| Metabolic vulnerabilities in cancer: A new therapeutic strategy. | El-Tanani M et al. | β | 2024 | β |
| Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment. | Li X et al. | β | 2024 | β |
| Molecular Engineering of Plasma Membrane and Mitochondria Dual-Targeted NIR-II AIE Photosensitizer Evoking Synergetic Pyroptosis and Apoptosis. | Zhuang J et al. | β | 2024 | β |
| Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review). | Xu Y et al. | β | 2024 | β |
| Multimodal epigenetic sequencing analysis (MESA) of cell-free DNA for non-invasive colorectal cancer detection. | Li Y et al. | β | 2024 | β |
| Multiomics approach towards characterization of tumor cell plasticity and its significance in precision and personalized medicine. | Aziz MA | β | 2024 | β |
| Multi-omics based artificial intelligence for cancer research. | Li L et al. | β | 2024 | β |
| Multi-view multi-level contrastive graph convolutional network for cancer subtyping on multi-omics data. | Yang B et al. | β | 2024 | β |
| Nephroblastoma-specific dysregulated gene SNHG15 with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation. | Chang M et al. | β | 2024 | β |
| Novel Isolating Approaches to Circulating Tumor Cell Enrichment Based on Microfluidics: A Review. | Qiao Z et al. | β | 2024 | β |
| Optical sensor reveals the hidden influence of cell dissociation on adhesion measurements. | KovΓ‘cs KD et al. | β | 2024 | β |
| Optimal fusion of genotype and drug embeddings in predicting cancer drug response. | Nguyen T et al. | β | 2024 | β |
| Oral tumor heterogeneity, its implications for patient monitoring and designing anti-cancer strategies. | Mishra R | β | 2024 | β |
| Overcoming Treatment Resistance in Medulloblastoma: Underlying Mechanisms and Potential Strategies. | Slika H et al. | β | 2024 | β |
| Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research. | Elbialy A et al. | β | 2024 | β |
| Platinum-based chemotherapy: trends in organic nanodelivery systems. | Santos JAV et al. | β | 2024 | β |
| Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma. | Sundaramoorthy S et al. | β | 2024 | β |
| Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota. | Chen L et al. | β | 2024 | β |
| Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development. | Gao W et al. | β | 2024 | β |
| Revelation of comprehensive cell profiling of primary and metastatic tumour ecosystems in oral squamous cell carcinoma by single-cell transcriptomic analysis. | Liao YH et al. | β | 2024 | β |
| Self-assembled aldehyde dehydrogenase-activatable nano-prodrug for cancer stem cell-enriched tumor detection and treatment. | Li B et al. | β | 2024 | β |
| Single-Cell Imaging of mRNA by Target RNA-Initiated RCA. | Ren X et al. | β | 2024 | β |
| SNORD88B-mediated WRN nucleolar trafficking drives self-renewal in liver cancer initiating cells and hepatocarcinogenesis. | Gu Y et al. | β | 2024 | β |
| Spatial transcriptomic revealed intratumor heterogeneity and cancer stem cell enrichment in colorectal cancer metastasis. | Zhou L et al. | β | 2024 | β |
| Stromal Rigidity Stress Accelerates Pancreatic Intraepithelial Neoplasia Progression and Chromosomal Instability via Nuclear Protein Tyrosine Kinase 2 Localization. | Ding LY et al. | β | 2024 | β |
| Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness. | Hu K et al. | β | 2024 | β |
| SUMOylation-induced membrane localization of TRPV1 suppresses proliferation and migration in gastric cancer cells. | Yang Y et al. | β | 2024 | β |
| Targeting FAP<i>Ξ±</i>-positive lymph node metastatic tumor cells suppresses colorectal cancer metastasis. | Fan S et al. | β | 2024 | β |
| The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytes. | Tarab-Ravski D et al. | β | 2024 | β |
| The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies. | Bamodu OA et al. | β | 2024 | β |
| The Investigation of <i>Quercus Infectoria</i> Gall Aqueous Extract Effect on the Cell Proliferation, Apoptosis and Expression of <i>CCND1</i>, <i>TP53</i>, <i>BCL2</i> and <i>BAX</i> Genes in Cell Line of Lung, Gastric and Esophageal Cancers. | Tofigh P et al. | β | 2024 | β |
| The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations. | Masciale V et al. | β | 2024 | β |
| The relationship between the tumor and its innervation: historical, methodical, morphological, and functional assessments - A minireview. | Blasko F et al. | β | 2024 | β |
| The role of circRNA in breast cancer drug resistance. | Yang S et al. | β | 2024 | β |
| The use of microphysiological systems to model metastatic cancer. | Jackson CE et al. | β | 2024 | β |
| Transient Regression of Breast Carcinoma After Diagnostic Biopsy and Tumor Heterogeneity: A Case Report. | De Faria Castro Fleury E et al. | β | 2024 | β |
| Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance. | Jamroze A et al. | β | 2024 | β |
| tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease. | Wu D et al. | β | 2024 | β |
| Uncovering Porphyrin Accumulation in the Tumor Microenvironment. | Adapa SR et al. | β | 2024 | β |
| Understanding the autophagic functions in cancer stem cell maintenance and therapy resistance. | Niharika et al. | β | 2024 | β |
| Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses. | Lee SE et al. | β | 2024 | β |
| 3D culture boosting fullerenol nanoparticles to induce calreticulin exposure on MCF-7 cells for enhanced macrophage-mediated cell removal. | Liu S et al. | β | 2023 | β |
| Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice. | Punetha A et al. | β | 2023 | β |
| Amyloid fibril-based thixotropic hydrogels for modeling of tumor spheroids in vitro. | Singh N et al. | β | 2023 | β |
| An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter. | Lai J et al. | β | 2023 | β |
| Antimicrobial agent chloroxylenol targets Ξ²βcateninβmediated Wnt signaling and exerts anticancer activity in colorectal cancer. | Sun Q et al. | β | 2023 | β |
| Application of molecular dynamics simulation in self-assembled cancer nanomedicine. | Xu X et al. | β | 2023 | β |
| Application of single-cell sequencing to the research of tumor microenvironment. | Chen S et al. | β | 2023 | β |
| ARAP1 negatively regulates stress fibers formation and metastasis in lung adenocarcinoma via controlling Rho signaling. | Zhang Z et al. | β | 2023 | β |
| A study of the interaction space of two lactate dehydrogenase isoforms (LDHA and LDHB) and some of their inhibitors using proteochemometrics modeling. | Damavandi S et al. | β | 2023 | β |
| Biophysical informatics reveals distinctive phenotypic signatures and functional diversity of single-cell lineages. | Chan TJ et al. | β | 2023 | β |
| Cancer Stem Cells and Chemoresistance in Ewing Sarcoma. | Dos Santos RP et al. | β | 2023 | β |
| Cancer stem cells and their niche in cancer progression and therapy. | Liu Q et al. | β | 2023 | β |
| Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: Insights and challenges. | Wu H et al. | β | 2023 | β |
| Cell population growth kinetics in the presence of stochastic heterogeneity of cell phenotype. | Wang Y et al. | β | 2023 | β |
| CellTracer: a comprehensive database to dissect the causative multilevel interplay contributing to cell development trajectories. | Guo Q et al. | β | 2023 | β |
| Circulating circRNA: a social butterfly in tumors. | Miao S et al. | β | 2023 | β |
| Clinical-mediated discovery of pyroptosis in CD8<sup>+</sup> T cell and NK cell reveals melanoma heterogeneity by single-cell and bulk sequence. | Zhang Y et al. | β | 2023 | β |
| Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape. | Maslah N et al. | β | 2023 | β |
| Colorectal Cancer Stem Cells and Targeted Agents. | Zhao H et al. | β | 2023 | β |
| Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. | Tan Z et al. | β | 2023 | β |
| Compression drives diverse transcriptomic and phenotypic adaptations in melanoma. | Zhang X et al. | β | 2023 | β |
| Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma. | Zhang J et al. | β | 2023 | β |
| Conventional MRI Feature Study on the Application Value in Differentiating High- and Low-grade Meningioma. | Tang L et al. | β | 2023 | β |
| Crossroad between the Heat Shock Protein and Inflammation Pathway in Acquiring Drug Resistance: A Possible Target for Future Cancer Therapeutics. | Somu P et al. | β | 2023 | β |
| Current therapy and drug resistance in metastatic castration-resistant prostate cancer. | Cai M et al. | β | 2023 | β |
| Development and validation of a gene model predicting lymph node metastasis and prognosis of oral squamous cell carcinoma based on single-cell and bulk RNA-seq analysis. | Han PZ et al. | β | 2023 | β |
| Development and validation of a ligand-receptor pairs signature to predict outcome and provide a therapeutic strategy in gastric cancer. | Yang W et al. | β | 2023 | β |
| Development of a Microfluidic Flow Cytometer with a Uniform Optical Field (Uni-ΞΌFCM) Enabling Quantitative Analysis of Single-Cell Proteins and Its Applications in Leukemia Gating, Tumor Classification, and Hierarchy of Cancer Stem Cells. | Gao C et al. | β | 2023 | β |
| Differential regional importance mapping for thyroid nodule malignancy prediction with potential to improve needle aspiration biopsy sampling reliability. | Wang L et al. | β | 2023 | β |
| Differentiation of benign and malignant breast lesions using diffusion-weighted imaging with a fractional-order calculus model. | Wang C et al. | β | 2023 | β |
| Distinct but interchangeable subpopulations of colorectal cancer cells with different growth fates and drug sensitivity. | Coppo R et al. | β | 2023 | β |
| DUX4 expression in cancer induces a metastable early embryonic totipotent program. | Smith AA et al. | β | 2023 | β |
| Dynamic changes in pathology and PD-L1 expression in a patient with metastatic lung adenocarcinoma who received pembrolizumab therapy followed by two salvage surgeries two years later: A case report. | Hong G et al. | β | 2023 | β |
| Dysregulated Signalling Pathways Driving Anticancer Drug Resistance. | Bou Antoun N et al. | β | 2023 | β |
| DZIP1 expressed in fibroblasts and tumor cells may affect immunosuppression and metastatic potential in gastric cancer. | Yin Y et al. | β | 2023 | β |
| Editorial for the Special Issue "Genetics and Genomics of Gastrointestinal Cancers: From Prevention to Treatment". | Marabelli M et al. | β | 2023 | β |
| Elucidating the Implications of Diverse Dynamical Responses in p53 Protein. | Charan K et al. | β | 2023 | β |
| Epigenetic mechanism of therapeutic resistance and potential of epigenetic therapeutics in chemorefractory prostate cancer. | Roy P et al. | β | 2023 | β |
| Evaluation of single-cell RNAseq labelling algorithms using cancer datasets. | Christensen E et al. | β | 2023 | β |
| Evolutionary reversion in tumorigenesis. | Nagahata Y et al. | β | 2023 | β |
| Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. | Li YR et al. | β | 2023 | β |
| Expression of <i>NORAD</i> correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapy. | Alves-Vale C et al. | β | 2023 | β |
| Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells. | Mancarella C et al. | β | 2023 | β |
| Harnessing cancer stem cell-derived exosomes to improve cancer therapy. | Yang J et al. | β | 2023 | β |
| High-Throughput Cellular Heterogeneity Analysis in Cell Migration at the Single-Cell Level. | Zhou M et al. | β | 2023 | β |
| How germline genes promote malignancy in cancer cells. | Bruggeman JW et al. | β | 2023 | β |
| Hyaluronic acid-functionalized lipoplexes and polyplexes as emerging nanocarriers for receptor-targeted cancer therapy. | Chandra J et al. | β | 2023 | β |
| Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship. | Ceranski AK et al. | β | 2023 | β |
| Identifying Cancer Type-Specific Transcriptional Programs through Network Analysis. | Kurup JT et al. | β | 2023 | β |
| Impact of Aluminium phthalocyanine nanoconjugate on melanoma stem cells. | Mkhobongo B et al. | β | 2023 | β |
| Impact of nanoparticles on amyloid Ξ²-induced Alzheimer's disease, tuberculosis, leprosy and cancer: a systematic review. | Chakraborty A et al. | β | 2023 | β |
| Integration of quantitative methods and mathematical approaches for the modeling of cancer cell proliferation dynamics. | Cotner M et al. | β | 2023 | β |
| Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy. | Cui Z et al. | β | 2023 | β |
| Interleukin-6 Induces Stem Cell Propagation through Liaison with the Sortilin-Progranulin Axis in Breast Cancer. | Berger K et al. | β | 2023 | β |
| LHP1-mediated epigenetic buffering of subgenome diversity and defense responses confers genome plasticity and adaptability in allopolyploid wheat. | Li Z et al. | β | 2023 | β |
| Ligand-independent EphA2 contributes to chemoresistance in small-cell lung cancer by enhancing PRMT1-mediated SOX2 methylation. | Liang S et al. | β | 2023 | β |
| Lipogenesis promotes mitochondrial fusion and maintains cancer stemness in human NSCLC. | Liu Z et al. | β | 2023 | β |
| Lysine-Specific Demethylase 1 Promises to Be a Novel Target in Cancer Drug Resistance: Therapeutic Implications. | Yang FF et al. | β | 2023 | β |
| Membrane Partitioning of TEMPO Discriminates Human Lung Cancer from Neighboring Normal Cells. | Gasymov OK et al. | β | 2023 | β |
| Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives. | Ibrahim J et al. | β | 2023 | β |
| Microfluidic single-cell migration chip reveals insights into the impact of extracellular matrices on cell movement. | Zhou M et al. | β | 2023 | β |
| Mitophagy initiates retrograde mitochondrial-nuclear signaling to guide retinal pigment cell heterogeneity. | Datta S et al. | β | 2023 | β |
| Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer. | Sharma A et al. | β | 2023 | β |
| Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance. | Nimisha et al. | β | 2023 | β |
| Molecular mechanistic pathways underlying the anticancer therapeutic efficiency of romidepsin. | El Omari N et al. | β | 2023 | β |
| Multicellular network analysis of melanoma heterogeneity by scRNA-seq. | Li S et al. | β | 2023 | β |
| Multiparametric detection and outcome prediction of pancreatic cancer involving dual-energy CT, diffusion-weighted MRI, and radiomics. | Koch V et al. | β | 2023 | β |
| Multi-Target Neural Differentiation (MTND) Therapeutic Cocktail to Suppress Brain Tumor. | Hu X et al. | β | 2023 | β |
| Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models. | Petrikaite V et al. | β | 2023 | β |
| Nano-Enabled Strategies for the Treatment of Lung Cancer: Potential Bottlenecks and Future Perspectives. | Alshammari MK et al. | β | 2023 | β |
| Nanomedicines Targeting Glioma Stem Cells. | Sabu A et al. | β | 2023 | β |
| Nattokinase-Mediated Regulation of Tumor Physical Microenvironment to Enhance Chemotherapy, Radiotherapy, and CAR-T Therapy of Solid Tumor. | Zhang Y et al. | β | 2023 | β |
| Neural induction drives body axis formation during embryogenesis, but a neural induction-like process drives tumorigenesis in postnatal animals. | Cao Y | β | 2023 | β |
| Non-Association of Driver Alterations in PTEN with Differential Gene Expression and Gene Methylation in IDH1 Wildtype Glioblastomas. | Mallik MK et al. | β | 2023 | β |
| Oncogenic role and drug sensitivity of ETV4 in human tumors: a pan-cancer analysis. | Zhang R et al. | β | 2023 | β |
| On tumoural growth and treatment under cellular dedifferentiation. | Fischer MM et al. | β | 2023 | β |
| Osteosarcoma and Its Advancement. | Basit Q et al. | β | 2023 | β |
| Pan-cancer proteogenomics connects oncogenic drivers to functional states. | Li Y et al. | β | 2023 | β |
| Patient-derived intrafemoral orthotopic xenografts of peripheral blood or bone marrow from acute myeloid and acute lymphoblastic leukemia patients: clinical characterization, methodology, and validation. | Li J et al. | β | 2023 | β |
| Perfusion-Based Fluorescent Dye Labeling to Sort Cancer Cells Based on Their Distance from Blood Vessels. | Kumar S | β | 2023 | β |
| Pharmacological ascorbate potentiates combination nanomedicines and reduces cancer cell stemness to prevent post-surgery recurrence and systemic metastasis. | Jiang X et al. | β | 2023 | β |
| Photothermal Attenuation of Cancer Cell Stemness, Chemoresistance, and Migration Using CD44-Targeted MoS<sub>2</sub> Nanosheets. | Liu J et al. | β | 2023 | β |
| Plasticity of circulating tumor cells in small cell lung cancer. | Seo J et al. | β | 2023 | β |
| Precision TherapyΒ of Recurrent Breast Cancer throughΒ Targeting Different MalignantΒ Tumor Cells withΒ a HER2/CD44-Targeted Hydrogel Nanobot. | Chen J et al. | β | 2023 | β |
| Profiling single cancer cell metabolism via high-content SRS imaging with chemical sparsity. | Tan Y et al. | β | 2023 | β |
| Radiogenomics: a key component of precision cancer medicine. | Liu Z et al. | β | 2023 | β |
| Recreating heterogeneity of bladder cancer microenvironment to study its recurrences and progression. | Bordeleau F et al. | β | 2023 | β |
| Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse. | Brown A et al. | β | 2023 | β |
| RNA-Seq Analysis of Extradomain A and Extradomain B Fibronectin as Extracellular Matrix Markers for Cancer. | Hall RC et al. | β | 2023 | β |
| RNA splicing factor Rbm25 underlies heterogeneous preleukemic clonal expansion in mice. | Bramlett C et al. | β | 2023 | β |
| Role of voltage-gated proton channel (Hv1) in cancer biology. | Alvear-Arias JJ et al. | β | 2023 | β |
| Senescence-based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies. | Lv MY et al. | β | 2023 | β |
| Sepsis and acute respiratory failure in patients with cancer: how can we improve care and outcomes even further? | Lyons PG et al. | β | 2023 | β |
| SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells. | Chen J et al. | β | 2023 | β |
| Single-cell RNA sequencing analysis reveals transcriptional heterogeneity of multiple primary lung cancer. | Guo W et al. | β | 2023 | β |
| Single-microbead space-confined digital quantification strategy (SMSDQ) for counting microRNAs at the single-molecule level. | Liang Y et al. | β | 2023 | β |
| Spatiotemporal regulation of cholangiocarcinoma growth and dissemination by peritumoral myofibroblasts in a Vcam1-dependent manner. | Tian C et al. | β | 2023 | β |
| Standardization of organoid culture in cancer research. | Zhou C et al. | β | 2023 | β |
| Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance. | Cui J et al. | β | 2023 | β |
| Targeting breast cancer stem cells directly to treat refractory breast cancer. | Pan L et al. | β | 2023 | β |
| Targeting cancer stem cells and signalling pathways through phytochemicals: A promising approach against colorectal cancer. | Liao W et al. | β | 2023 | β |
| Targeting intratumor heterogeneity suppresses colorectal cancer chemoresistance and metastasis. | Chao S et al. | β | 2023 | β |
| Targeting the metastatic niche: Single-cell lineage tracing in prime time. | Sommer ER et al. | β | 2023 | β |
| The Association of Oral Microbiome Dysbiosis with Gastrointestinal Cancers and Its Diagnostic Efficacy. | Asili P et al. | β | 2023 | β |
| The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review. | Shafi O et al. | β | 2023 | β |
| The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential. | Slama Y et al. | β | 2023 | β |
| The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities. | Boylan J et al. | β | 2023 | β |
| Therapeutic targeting of leukemia stem cells in acute myeloid leukemia. | Barbosa K et al. | β | 2023 | β |
| The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges. | Hu Q et al. | β | 2023 | β |
| The transcription factor DUX4 orchestrates translational reprogramming by broadly suppressing translation efficiency and promoting expression of DUX4-induced mRNAs. | Hamm DC et al. | β | 2023 | β |
| Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer. | Lindfors H et al. | β | 2023 | β |
| Tracking tumor heterogeneity and progression with near-infrared II fluorophores. | Xin Q et al. | β | 2023 | β |
| Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma. | Biswas A et al. | β | 2023 | β |
| Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses. | Monaco ML et al. | β | 2023 | β |
| Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition. | Wada H et al. | β | 2023 | β |
| Ultrathin 2D Pd/Cu Single-Atom MOF Nanozyme to Synergistically Overcome Chemoresistance for Multienzyme Catalytic Cancer Therapy. | Guan X et al. | β | 2023 | β |
| Understanding cancer stem cells and plasticity: Towards better therapeutics. | Warrier NM et al. | β | 2023 | β |
| ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells. | Murakami K et al. | β | 2022 | β |
| A high-throughput technique to map cell images to cell positions using a 3D imaging flow cytometer. | Zhang Z et al. | β | 2022 | β |
| ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. | Law AMK et al. | β | 2022 | β |
| A mathematical model for phenotypic heterogeneity in breast cancer with implications for therapeutic strategies. | Li X et al. | β | 2022 | β |
| AMP-activated protein kinase promotes breast cancer stemness and drug resistance. | Andugulapati SB et al. | β | 2022 | β |
| A multi-omic approach reveals utility of CD45 expression in prognosis and novel target discovery. | Ye N et al. | β | 2022 | β |
| Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer. | DurΓ©ndez-SΓ‘ez E et al. | β | 2022 | β |
| Analyzing the relationship between the vitamin D deficiency and COVID-19 mortality rate and modeling the time-delay interactions between body's immune healthy cells, infected cells, and virus particles with the effect of vitamin D levels. | Pham H | β | 2022 | β |
| An Epigenetic <i>LINE-1</i>-Based Mechanism in Cancer. | Lavia P et al. | β | 2022 | β |
| An Epigenetic Role of Mitochondria in Cancer. | Liu Y et al. | β | 2022 | β |
| A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma. | Zhou Y et al. | β | 2022 | β |
| An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come? | Armando F et al. | β | 2022 | β |
| A Potential New Treatment for High-Grade Glioma: A Study Assessing Repurposed Drug Combinations against Patient-Derived High-Grade Glioma Cells. | Lastakchi S et al. | β | 2022 | β |
| Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. | Sheikh A et al. | β | 2022 | β |
| A Road Map toward Field-Effect Transistor Biosensor Technology for Early Stage Cancer Detection. | Eswaran M et al. | β | 2022 | β |
| A widespread length-dependent splicing dysregulation in cancer. | Zhang S et al. | β | 2022 | β |
| Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer. | Samad A et al. | β | 2022 | β |
| Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma. | Yabo YA et al. | β | 2022 | β |
| Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy. | Pienta KJ et al. | β | 2022 | β |
| Cancer immunomodulation using bispecific aptamers. | Thomas BJ et al. | β | 2022 | β |
| Cancer metastasis is related to normal tissue stemness. | Peng XY et al. | β | 2022 | β |
| Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis. | Kapoor-Narula U et al. | β | 2022 | β |
| Causes and functional intricacies of inter- and intratumor heterogeneity of primary liver cancers. | Khatib SA et al. | β | 2022 | β |
| Cellular and molecular mechanisms of plasticity in cancer. | Torborg SR et al. | β | 2022 | β |
| Cervical cancer heterogeneity: a constant battle against viruses and drugs. | Sun Q et al. | β | 2022 | β |
| Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel. | Zhao J et al. | β | 2022 | β |
| Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer. | Zheng H et al. | β | 2022 | β |
| Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma. | Qazi MA et al. | β | 2022 | β |
| Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications. | Mehraj U et al. | β | 2022 | β |
| Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through <i>Ξ²</i>-catenin/MDR1 signaling to sustain chemoresistance. | Ghatak S et al. | β | 2022 | β |
| Clinical and translational values of spatial transcriptomics. | Zhang L et al. | β | 2022 | β |
| Clonal barcoding with qPCR detection enables live cell functional analyses for cancer research. | Guo Q et al. | β | 2022 | β |
| Complex Elucidation of Cells-of-Origin in Pediatric Soft Tissue Sarcoma: From Concepts to Real Life, Hide-and-Seek through Epigenetic and Transcriptional Reprogramming. | Savary C et al. | β | 2022 | β |
| Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma. | Lee YC et al. | β | 2022 | β |
| Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma. | Wang G et al. | β | 2022 | β |
| Copper-based metal-organic frameworks for biomedical applications. | Cun JE et al. | β | 2022 | β |
| Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer. | Solis RN et al. | β | 2022 | β |
| CXCL8 in Tumor Biology and Its Implications for Clinical Translation. | Xiong X et al. | β | 2022 | β |
| Decoding molecular programs in melanoma brain metastases. | Radke J et al. | β | 2022 | β |
| Design, Synthesis, and Targeted Delivery of an Immune Stimulant that Selectively Reactivates Exhausted CAR T Cells. | Napoleon JV et al. | β | 2022 | β |
| Detecting spatially co-expressed gene clusters with functional coherence by graph-regularized convolutional neural network. | Song T et al. | β | 2022 | β |
| Development of a Multicellular 3D Tumor Model to Study Cellular Heterogeneity and Plasticity in NSCLC Tumor Microenvironment. | Arora L et al. | β | 2022 | β |
| Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy. | Huang F et al. | β | 2022 | β |
| Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer. | Wang R et al. | β | 2022 | β |
| Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development. | Wen Z et al. | β | 2022 | β |
| DNA Logic Circuits for Cancer Theranostics. | Chen J et al. | β | 2022 | β |
| Drug susceptibility testing of circulating lung cancer cells for personalized treatment. | Balakrishnan A et al. | β | 2022 | β |
| Dynamic Characteristics and Predictive Capability of Tumor Voxel Dose-Response Assessed Using <sup>18</sup>F-FDG PET/CT Imaging Feedback. | Chen S et al. | β | 2022 | β |
| Effect of dedifferentiation on noise propagation in cellular hierarchy. | Wang Y et al. | β | 2022 | β |
| Effects of Wound Fluid on Breast Cancer-derived Spheroids in a 3D Culture System: A Case Series Study. | Hojat A et al. | β | 2022 | β |
| Emergence of hybrid states of stem-like cancer cells correlates with poor prognosis in oral cancer. | Vipparthi K et al. | β | 2022 | β |
| Epithelial-Mesenchymal Plasticity Induced by Discontinuous Exposure to TGFΞ²1 Promotes Tumour Growth. | Santos M et al. | β | 2022 | β |
| ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transition. | Cai S et al. | β | 2022 | β |
| Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. | Cao S et al. | β | 2022 | β |
| Evaluation of single-cell RNA-seq clustering algorithms on cancer tumor datasets. | Mahalanabis A et al. | β | 2022 | β |
| Evaluation of the 18F-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma. | Simionato Perrotta F et al. | β | 2022 | β |
| Facile Preparation of Three-Dimensional Wafer with Interconnected Porous Structure for High-Performance Capture and Nondestructive Release of Circulating Tumor Cells. | Li M et al. | β | 2022 | β |
| Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate <i>cancer</i>. | Zhou H et al. | β | 2022 | β |
| Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis. | Zhang Y et al. | β | 2022 | β |
| Genomic mapping of copy number variations influencing immune response in breast cancer. | LΓ³pez-Cade I et al. | β | 2022 | β |
| Gynecologic Cancer, Cancer Stem Cells, and Possible Targeted Therapies. | Keyvani V et al. | β | 2022 | β |
| Human cancer cells generate spontaneous calcium transients and intercellular waves that modulate tumor growth. | Liang C et al. | β | 2022 | β |
| Hydrogels for Single-Cell Microgel Production: Recent Advances and Applications. | Tiemeijer BM et al. | β | 2022 | β |
| Identification, Culture and Targeting of Cancer Stem Cells. | Herreros-Pomares A | β | 2022 | β |
| Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma. | Wang X et al. | β | 2022 | β |
| Identification of vascular cues contributing to cancer cell stemness and function. | Kumar S et al. | β | 2022 | β |
| Image quality and whole-lesion histogram and texture analysis of diffusion-weighted imaging of breast MRI based on advanced ZOOMit and simultaneous multislice readout-segmented echo-planar imaging. | Sun K et al. | β | 2022 | β |
| Impact of Cancer Stem Cells on Therapy Resistance in Gastric Cancer. | Otaegi-Ugartemendia M et al. | β | 2022 | β |
| Improved risk stratification by PET-based intratumor heterogeneity in children with high-risk neuroblastoma. | Li C et al. | β | 2022 | β |
| Investigating the Potential Use of Chemical Biopsy Devices to Characterize Brain Tumor Lipidomes. | Bogusiewicz J et al. | β | 2022 | β |
| In Vitro Photodynamic Treatment Modality for A375 Melanoma Cell Line Using a Sulphonated Aluminum Phthalocyanine Chloride-Photosensitizer-Gold Nanoparticle Conjugate. | Mkhobongo B et al. | β | 2022 | β |
| LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis. | Cheng Q et al. | β | 2022 | β |
| Limiting dilution assay to quantify the self-renewal potential of cancer stem cells in hepatocellular carcinoma. | Lai Y et al. | β | 2022 | β |
| Lipid metabolism of cancer stem cells. | Liu H et al. | β | 2022 | β |
| LncRNAs in breast cancer: a link to future approaches. | Sideris N et al. | β | 2022 | β |
| LncRNAs, the Molecules Involved in Communications With Colorectal Cancer Stem Cells. | Fan B et al. | β | 2022 | β |
| Mathematical characterization of population dynamics in breast cancer cells treated with doxorubicin. | Yang EY et al. | β | 2022 | β |
| Melanoma Tumour Vascularization and Tissue-Resident Endothelial Progenitor Cells. | Hashemi G et al. | β | 2022 | β |
| Metabolic heterogeneity protects metastatic mucosal melanomas cells from ferroptosis. | Lin W et al. | β | 2022 | β |
| MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state. | Zhang WC et al. | β | 2022 | β |
| Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma. | Tourigny DS et al. | β | 2022 | β |
| [Molecular markers of neuro-oncogenesis in patients with glioblastoma]. | Kopylov AM et al. | β | 2022 | β |
| Molecular Regulation of Androgen Receptors in Major Female Reproductive System Cancers. | Wu S et al. | β | 2022 | β |
| Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches. | Emran TB et al. | β | 2022 | β |
| N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer. | Nie X et al. | β | 2022 | β |
| Nanog, as a key cancer stem cell marker in tumor progression. | Vasefifar P et al. | β | 2022 | β |
| Neural is Fundamental: Neural Stemness as the Ground State of Cell Tumorigenicity and Differentiation Potential. | Cao Y | β | 2022 | β |
| Next-generation cancer organoids. | LeSavage BL et al. | β | 2022 | β |
| Non-coding RNAs and glioma: Focus on cancer stem cells. | Rajabi A et al. | β | 2022 | β |
| Non-enzymatic heparanase enhances gastric tumor proliferation via TFEB-dependent autophagy. | Yang M et al. | β | 2022 | β |
| OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma. | Xu Z et al. | β | 2022 | β |
| Optical Cellular Micromotion: A New Paradigm to Measure Tumor Cells Invasion within Gels Mimicking the 3D Tumor Environments. | Guo Z et al. | β | 2022 | β |
| Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors. | Liang Q et al. | β | 2022 | β |
| Pan-cancer analysis revealed the significance of the GTPBP family in cancer. | Hu Y et al. | β | 2022 | β |
| Pathway trajectory analysis with tensor imputation reveals drug-induced single-cell transcriptomic landscape. | Iwata M et al. | β | 2022 | β |
| PD-L1 Activity Is Associated with Partial EMT and Metabolic Reprogramming in Carcinomas. | Muralidharan S et al. | β | 2022 | β |
| Peritoneal carcinomatosis secondary to metastatic lung cancer complicated with acute suppurative appendicitis: A case report and literature review. | Fu JX et al. | β | 2022 | β |
| Phenotyping clonal populations of glioma stem cell reveals a high degree of plasticity in response to changes of microenvironment. | Innes JA et al. | β | 2022 | β |
| Plasticity within Aldehyde Dehydrogenase-Positive Cells Determines Prostate Cancer Radiosensitivity. | Schwarz FM et al. | β | 2022 | β |
| Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy. | Fahira AI et al. | β | 2022 | β |
| Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models. | Li W et al. | β | 2022 | β |
| Quantum dots based in-vitro co-culture cancer model for identification of rare cancer cell heterogeneity. | Vyshnava SS et al. | β | 2022 | β |
| Rapid Access to Ironomycin Derivatives by Click Chemistry. | Antoszczak M et al. | β | 2022 | β |
| Recapitulating Tumor Hypoxia in a Cleanroom-Free, Liquid-Pinning-Based Microfluidic Tumor Model. | Oh JM et al. | β | 2022 | β |
| Recent developments in silver nanoparticles utilized for cancer treatment and diagnosis: a patent review. | Patil SM et al. | β | 2022 | β |
| Recent progress of gene circuit designs in immune cell therapies. | Lee S et al. | β | 2022 | β |
| Regulation of developmental hierarchy in <i>Drosophila</i> neural stem cell tumors by COMPASS and Polycomb complexes. | Gaultier C et al. | β | 2022 | β |
| Regulation of Metastasis in Ewing Sarcoma. | Li M et al. | β | 2022 | β |
| Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention. | Tamamouna V et al. | β | 2022 | β |
| Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment. | Li F et al. | β | 2022 | β |
| Relationship between Tumor Infiltrating Immune Cells and Tumor Metastasis and Its Prognostic Value in Cancer. | Li HX et al. | β | 2022 | β |
| Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy. | Cui Y et al. | β | 2022 | β |
| RNA Modifications in Gastrointestinal Cancer: Current Status and Future Perspectives. | Zhang X et al. | β | 2022 | β |
| Roadmap on plasticity and epigenetics in cancer. | Foo J et al. | β | 2022 | β |
| Salinomycin as a potent anticancer stem cell agent: State of the art and future directions. | Qi D et al. | β | 2022 | β |
| Scales of Cancer Evolution: Selfish Genome or Cooperating Cells? | BrutovskΓ½ B | β | 2022 | β |
| SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021). | de la Haba-Rodriguez J et al. | β | 2022 | β |
| Single-cell sequencing: a promising approach for uncovering the mechanisms of tumor metastasis. | Han Y et al. | β | 2022 | β |
| Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis. | Zheng X et al. | β | 2022 | β |
| Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells. | Pan Z et al. | β | 2022 | β |
| SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. | Dai L et al. | β | 2022 | β |
| Spatial specific delivery of combinational chemotherapeutics to combat intratumoral heterogeneity. | Wang K et al. | β | 2022 | β |
| Specific cell differentiation in breast cancer: a basis for histological classification. | Rakha E et al. | β | 2022 | β |
| Spotlight on Photoactivatable Liposomes beyond Drug Delivery: An Enabler of Multitargeting of Molecular Pathways. | Saad MA et al. | β | 2022 | β |
| Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers. | Kyte JA | β | 2022 | β |
| Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters. | van Gils N et al. | β | 2022 | β |
| Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation. | Zhang HL et al. | β | 2022 | β |
| Texture analysis imaging "what a clinical radiologist needs to know". | Corrias G et al. | β | 2022 | β |
| The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells. | Correnti M et al. | β | 2022 | β |
| The Hematology of Tomorrow Is Here-Preclinical Models Are Not: Cell Therapy for Hematological Malignancies. | Arranz L | β | 2022 | β |
| The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. | Alhaddad L et al. | β | 2022 | β |
| The Role of <i>in silico</i> Research in Developing Nanoparticle-Based Therapeutics. | Jayasinghe MK et al. | β | 2022 | β |
| The role of RNA processing and regulation in metastatic dormancy. | Parker KA et al. | β | 2022 | β |
| The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer. | Karahan Εen NP et al. | β | 2022 | β |
| Three-dimensional in vitro culture models in oncology research. | Jubelin C et al. | β | 2022 | β |
| Tracking the Development of Cancer Care After 75 Years of Independence: India's Fight Against Cancer Since 1947. | Mehta A | β | 2022 | β |
| Transcriptional Factor Repertoire of Breast Cancer in 3D Cell Culture Models. | Γzkan H et al. | β | 2022 | β |
| Transcriptional Fluctuations Govern the Serum-Dependent Cell Cycle Duration Heterogeneities in Mammalian Cells. | Govindaraj V et al. | β | 2022 | β |
| Transcription factor binding process is the primary driver of noise in gene expression. | Parab L et al. | β | 2022 | β |
| Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours. | Crucitta S et al. | β | 2022 | β |
| Tumoral heterogeneity in neuroblastoma. | Gomez RL et al. | β | 2022 | β |
| Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B. | Musella M et al. | β | 2022 | β |
| Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing. | Li XY et al. | β | 2022 | β |
| Universal Markers Unveil Metastatic Cancerous Cross-Sections at Nanoscale. | Bakalis E et al. | β | 2022 | β |
| Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies. | Lerario AM et al. | β | 2022 | β |
| Volumetric Evaluation of Staging <sup>18</sup>F-FDG PET/CT Images in Patients with Esophageal Cancer. | Karahan Εen NP et al. | β | 2022 | β |
| Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis. | Liu Y et al. | β | 2022 | β |
| Yeast-based evolutionary modeling of androgen receptor mutations and natural selection. | Zhang H et al. | β | 2022 | β |
| Ξ±2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth. | Gc S et al. | β | 2022 | β |
| ΞNp63/p73 drive metastatic colonization by controlling a regenerative epithelial stem cell program in quasi-mesenchymal cancer stem cells. | Lambert AW et al. | β | 2022 | β |
| Ξ€he Effect of Opioid Administration on Cytologic and Histopathologic Diagnosis of Canine Cutaneous Mast Cell Tumors Treated by Surgical Excision. | Marouda C et al. | β | 2022 | β |
| Abnormal Aggregation of Invasive Cancer Cells Induced by Collective Polarization and ECM-Mediated Mechanical Coupling in Coculture Systems. | Wang X et al. | β | 2021 | β |
| An adaptive method of defining negative mutation status for multi-sample comparison using next-generation sequencing. | Hutson N et al. | β | 2021 | β |
| A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells. | Shen S et al. | β | 2021 | β |
| A narrative review of imatinib-resistant gastrointestinal stromal tumors. | Hayashi Y et al. | β | 2021 | β |
| Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials. | Chung WM et al. | β | 2021 | β |
| An emerging role for cellular crosstalk in the cancer stem cell niche. | Oshimori N et al. | β | 2021 | β |
| An epigenetic switch regulates the ontogeny of AXL-positive/EGFR-TKi-resistant cells by modulating miR-335 expression. | Safaric Tepes P et al. | β | 2021 | β |
| A network-based deep learning methodology for stratification of tumor mutations. | Liu C et al. | β | 2021 | β |
| Anticancer Mechanisms of Salinomycin in Breast Cancer and Its Clinical Applications. | Wang H et al. | β | 2021 | β |
| A Personalized Therapeutics Approach Using an <i>In Silico Drosophila Patient Model</i> Reveals Optimal Chemo- and Targeted Therapy Combinations for Colorectal Cancer. | Gondal MN et al. | β | 2021 | β |
| A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer. | Angius A et al. | β | 2021 | β |
| Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery. | Kwon YW et al. | β | 2021 | β |
| Application of Single-Cell Multi-Omics in Dissecting Cancer Cell Plasticity and Tumor Heterogeneity. | Pan D et al. | β | 2021 | β |
| A Signature Enrichment Design with Bayesian Adaptive Randomization. | Xia F et al. | β | 2021 | β |
| Assembly Transformation Jointly Driven by the LAP Enzyme and GSH Boosting Theranostic Capability for Effective Tumor Therapy. | Wang A et al. | β | 2021 | β |
| Association of human breast cancer CD44<sup>-</sup>/CD24<sup>-</sup> cells with delayed distant metastasis. | Qiao X et al. | β | 2021 | β |
| Biophysical Informatics Approach For Quantifying Phenotypic Heterogeneity In Cancer Cell Migration In Confined Microenvironments. | Zhang X et al. | β | 2021 | β |
| BRAF Heterogeneity in Melanoma. | Ito T et al. | β | 2021 | β |
| Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical Perspective. | PiΓ±a-SΓ‘nchez P et al. | β | 2021 | β |
| Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells. | Pienta KJ et al. | β | 2021 | β |
| Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis. | Dzobo K et al. | β | 2021 | β |
| Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. | Aramini B et al. | β | 2021 | β |
| Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs. | Tomei S et al. | β | 2021 | β |
| Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer. | Zhang H et al. | β | 2021 | β |
| Cancer Stem Cells in Oropharyngeal Cancer. | Gunduz M et al. | β | 2021 | β |
| Cancer Stem Cells-Key Players in Tumor Relapse. | Marzagalli M et al. | β | 2021 | β |
| Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy. | Kaur J et al. | β | 2021 | β |
| Capillary-Mediated Single-Cell Dispenser. | Wu L et al. | β | 2021 | β |
| Cell-morphodynamic phenotype classification with application to cancer metastasis using cell magnetorotation and machine-learning. | Elbez R et al. | β | 2021 | β |
| Characterizing dedifferentiation of thyroid cancer by integrated analysis. | Luo H et al. | β | 2021 | β |
| Chromatin and Epigenetic Rearrangements in Embryonic Stem Cell Fate Transitions. | Sun L et al. | β | 2021 | β |
| Circular RNA circIPO11 drives self-renewal of liver cancer initiating cells via Hedgehog signaling. | Gu Y et al. | β | 2021 | β |
| Colorectal Cancer Stem Cell States Uncovered by Simultaneous Single-Cell Analysis of Transcriptome and Telomeres. | Wang H et al. | β | 2021 | β |
| Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer. | Okamoto T et al. | β | 2021 | β |
| Comprehensive analysis of metastatic gastric cancer tumour cells using single-cell RNA-seq. | Wang B et al. | β | 2021 | β |
| Conditionally Reprogrammed Cells and Robotic High-Throughput Screening for Precision Cancer Therapy. | Alkhilaiwi F | β | 2021 | β |
| Conflicting metabolic alterations in cancer stem cells and regulation by the stromal niche. | Yasuda T et al. | β | 2021 | β |
| Construction and Verification of a Hypoxia-Related 4-lncRNA Model for Prediction of Breast Cancer. | Zhao Y et al. | β | 2021 | β |
| Construction of Hierarchical-Targeting pH-Sensitive Liposomes to Reverse Chemotherapeutic Resistance of Cancer Stem-like Cells. | Ba S et al. | β | 2021 | β |
| Cutaneous and uveal melanoma: two different cancers in therapeutic needs. | Bertolotto C | β | 2021 | β |
| Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses. | Contreras-Trujillo H et al. | β | 2021 | β |
| Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma. | Sharma R et al. | β | 2021 | β |
| Dissecting the mechanism of temozolomide resistance and its association with the regulatory roles of intracellular reactive oxygen species in glioblastoma. | Chien CH et al. | β | 2021 | β |
| Dll1<sup>+</sup> quiescent tumor stem cells drive chemoresistance in breast cancer through NF-ΞΊB survival pathway. | Kumar S et al. | β | 2021 | β |
| Do Lipid-based Nanoparticles Hold Promise for Advancing the Clinical Translation of Anticancer Alkaloids? | Loh JS et al. | β | 2021 | β |
| Emerging Role of Chimeric RNAs in Cell Plasticity and Adaptive Evolution of Cancer Cells. | Mukherjee S et al. | β | 2021 | β |
| Engineering in Medicine To Address the Challenge of Cancer Drug Resistance: From Micro- and Nanotechnologies to Computational and Mathematical Modeling. | Craig M et al. | β | 2021 | β |
| Epigenetic instability may alter cell state transitions and anticancer drug resistance. | Saini A et al. | β | 2021 | β |
| Epigenetic Signaling of Cancer Stem Cells During Inflammation. | Liu Z et al. | β | 2021 | β |
| Equipping Natural Killer Cells with Cetuximab through Metabolic Glycoengineering and Bioorthogonal Reaction for Targeted Treatment of KRAS Mutant Colorectal Cancer. | Wang X et al. | β | 2021 | β |
| Establishment of Novel Prostate Cancer Risk Subtypes and A Twelve-Gene Prognostic Model. | Zhang E et al. | β | 2021 | β |
| Evolutionary Mechanisms of Cancer Suggest Rational Therapeutic Approaches. | Balzerano A et al. | β | 2021 | β |
| Expression of cathepsins B and D by cancer stem cells in head and neck metastatic malignant melanoma. | Sangster AB et al. | β | 2021 | β |
| Extracellular Vesicles: An Emerging Mechanism Governing the Secretion and Biological Roles of Tenascin-C. | Albacete-Albacete L et al. | β | 2021 | β |
| FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma. | Maehara O et al. | β | 2021 | β |
| Fibrotic Phenotype of Peritumour Mesenteric Adipose Tissue in Human Colon Cancer: A Potential Hallmark of Metastatic Properties. | Tabuso M et al. | β | 2021 | β |
| Force balancing ACT-IN the tumor microenvironment: Cytoskeletal modifications in cancer and stromal cells to promote malignancy. | Dawson MR et al. | β | 2021 | β |
| From cell spheroids to vascularized cancer organoids: Microfluidic tumor-on-a-chip models for preclinical drug evaluations. | Wu Y et al. | β | 2021 | β |
| GALNT6 Knockdown Inhibits the Proliferation and Migration of Colorectal Cancer Cells and Increases the Sensitivity of Cancer Cells to 5-FU. | Peng X et al. | β | 2021 | β |
| Generating CAR T cells from tumor-infiltrating lymphocytes. | Mills JK et al. | β | 2021 | β |
| Genetically Encoded Fluorescent Biosensors for Biomedical Applications. | Ovechkina VS et al. | β | 2021 | β |
| Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution. | Shlyakhtina Y et al. | β | 2021 | β |
| Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT). | Marret G et al. | β | 2021 | β |
| Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges. | Piper K et al. | β | 2021 | β |
| G-protein-coupled receptor GPR17 inhibits glioma development by increasing polycomb repressive complex 1-mediated ROS production. | Liu H et al. | β | 2021 | β |
| Group phenotypic composition in cancer. | Capp JP et al. | β | 2021 | β |
| Hedgehog Pathway Inhibitors against Tumor Microenvironment. | Gampala S et al. | β | 2021 | β |
| HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness. | Pupa SM et al. | β | 2021 | β |
| HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia. | Li X et al. | β | 2021 | β |
| High-Precision Quantitative Analysis Reveals Carcinoembryonic Protein Expression Differs Among Colorectal Cancer Primary Foci and Metastases to Different Sites. | Zhu Y et al. | β | 2021 | β |
| Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy. | Gao M et al. | β | 2021 | β |
| Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter. | Li J et al. | β | 2021 | β |
| Identification of combinations of somatic mutations that predict cancer survival and immunotherapy benefit. | Gussow AB et al. | β | 2021 | β |
| Identification of DNA Damage Repair-Associated Prognostic Biomarkers for Prostate Cancer Using Transcriptomic Data Analysis. | Teng PC et al. | β | 2021 | β |
| Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics. | Velten L et al. | β | 2021 | β |
| Identification of marker genes and cell subtypes in castration-resistant prostate cancer cells. | Lin XD et al. | β | 2021 | β |
| Identification of TAZ-Dependent Breast Cancer Vulnerabilities Using a Chemical Genomics Screening Approach. | Shen H et al. | β | 2021 | β |
| Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma. | Tang R et al. | β | 2021 | β |
| Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma. | Ikeda S et al. | β | 2021 | β |
| Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens. | Xu M et al. | β | 2021 | β |
| Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease. | Lak NSM et al. | β | 2021 | β |
| Improving the cancer prevention/treatment role of carotenoids through various nano-delivery systems. | Zare M et al. | β | 2021 | β |
| Insight Into Chromatin-Enriched RNA: A Key Chromatin Regulator in Tumors. | Zhang J et al. | β | 2021 | β |
| Integrative Analysis of Biomarkers Through Machine Learning Identifies Stemness Features in Colorectal Cancer. | Wei R et al. | β | 2021 | β |
| Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains. | Gopi LK et al. | β | 2021 | β |
| Interaction between Ras and Src clones causes interdependent tumor malignancy via Notch signaling in Drosophila. | Enomoto M et al. | β | 2021 | β |
| Intra-heterogeneity in transcription and chemoresistant property of leukemia-initiating cells in murine Setd2<sup>-/-</sup> acute myeloid leukemia. | Song J et al. | β | 2021 | β |
| Intra-Tumoral Expression of SLC7A11 Is Associated with Immune Microenvironment, Drug Resistance, and Prognosis in Cancers: A Pan-Cancer Analysis. | He J et al. | β | 2021 | β |
| Intrinsic and chemically-induced daughter number variations in cancer cell lines. | Tyagi IS et al. | β | 2021 | β |
| Investigating Inter- and Intrasample Diversity of Single-Cell RNA Sequencing Datasets. | Ferrall-Fairbanks MC et al. | β | 2021 | β |
| In vitro models of intestinal epithelium: Toward bioengineered systems. | Creff J et al. | β | 2021 | β |
| Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment. | Yang N et al. | β | 2021 | β |
| Label-Free Deep Profiling of the Tumor Microenvironment. | You S et al. | β | 2021 | β |
| LAMC1 upregulation via TGFΞ² induces inflammatory cancer-associated fibroblasts in esophageal squamous cell carcinoma via NF-ΞΊB-CXCL1-STAT3. | Fang L et al. | β | 2021 | β |
| Landscape of cell heterogeneity and evolutionary trajectory in ulcerative colitis-associated colon cancer revealed by single-cell RNA sequencing. | Wang Q et al. | β | 2021 | β |
| Liquid biopsy in NSCLC: a new challenge in radiation therapy. | Perillo A et al. | β | 2021 | β |
| Long noncoding RNA FER1L4 promotes the malignant processes of papillary thyroid cancer by targeting the miR-612/ Cadherin 4 axis. | Wu L et al. | β | 2021 | β |
| Lymph node response to chemoradiotherapy in oesophageal cancer patients: relationship with radiotherapy fields. | Koemans WJ et al. | β | 2021 | β |
| Magnetic Nanoparticle-Based Hyperthermia Mediates Drug Delivery and Impairs the Tumorigenic Capacity of Quiescent Colorectal Cancer Stem Cells. | Fernandes S et al. | β | 2021 | β |
| Many Distinct Ways Lead to Drug Resistance in <i>BRAF</i>- and <i>NRAS</i>-Mutated Melanomas. | Vachtenheim J et al. | β | 2021 | β |
| Mathematical Modeling of Plasticity and Heterogeneity in EMT. | Tripathi S et al. | β | 2021 | β |
| Mechanisms of cancer stem cell senescence: Current understanding and future perspectives. | Zhang DY et al. | β | 2021 | β |
| Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy. | Huang F et al. | β | 2021 | β |
| Molecular features and gene expression signature of metastatic colorectal cancer (Review). | Poturnajova M et al. | β | 2021 | β |
| Morphodynamic signatures of MDA-MB-231 single cells and cell doublets undergoing invasion in confined microenvironments. | Zhang X et al. | β | 2021 | β |
| Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation. | Quintanal-Villalonga A et al. | β | 2021 | β |
| Multiregional Sequencing of IDH-WT Glioblastoma Reveals High Genetic Heterogeneity and a Dynamic Evolutionary History. | Franceschi S et al. | β | 2021 | β |
| MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types. | Wu SY et al. | β | 2021 | β |
| Nanoparticle-Mediated Lipid Metabolic Reprogramming of T Cells in Tumor Microenvironments for Immunometabolic Therapy. | Kim D et al. | β | 2021 | β |
| Nanopore Sequencing Reveals Global Transcriptome Signatures of Mitochondrial and Ribosomal Gene Expressions in Various Human Cancer Stem-like Cell Populations. | Witte KE et al. | β | 2021 | β |
| Negative correlation of single-cell <i>PAX3:FOXO1</i> expression with tumorigenicity in rhabdomyosarcoma. | Regina C et al. | β | 2021 | β |
| New Insights into the Importance of Long Non-Coding RNAs in Lung Cancer: Future Clinical Approaches. | Ghahramani Almanghadim H et al. | β | 2021 | β |
| Next-generation sequencing of cancer genomes: lessons learned. | Corrigan AE et al. | β | 2021 | β |
| Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer. | Novak KujundΕΎiΔ R et al. | β | 2021 | β |
| N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine-A Review. | Kyr M et al. | β | 2021 | β |
| Novel insights into exosomal circular RNAs: Redefining intercellular communication in cancer biology. | Lin H et al. | β | 2021 | β |
| N<sup>1</sup>-methyladenosineΒ methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism. | Wang Y et al. | β | 2021 | β |
| Oncological Ligand-Target Binding Systems and Developmental Approaches for Cancer Theranostics. | Jeevanandam J et al. | β | 2021 | β |
| Opportunities and challenges of glioma organoids. | Xu X et al. | β | 2021 | β |
| Ovarian Cancer Stem Cells: Characterization and Role in Tumorigenesis. | Saha S et al. | β | 2021 | β |
| Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy. | Aboelella NS et al. | β | 2021 | β |
| Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship. | Pandkar MR et al. | β | 2021 | β |
| Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy. | Nawara HM et al. | β | 2021 | β |
| Phylogenetic analysis of combined lobular and ductal carcinoma of the breast. | Kobayashi H et al. | β | 2021 | β |
| Plasma-Conditioned Liquids as Anticancer Therapies In Vivo: Current State and Future Directions. | SolΓ©-MartΓ X et al. | β | 2021 | β |
| Plasticity in Colorectal Cancer: Why Cancer Cells Differentiate. | Walter RJ et al. | β | 2021 | β |
| PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR/Akt/NF-ΞΊB/IL8 pathway. | Fang L et al. | β | 2021 | β |
| Polymer-lipid hybrid nanovesicle-enabled combination of immunogenic chemotherapy and RNAi-mediated PD-L1 knockdown elicits antitumor immunity against melanoma. | Wang C et al. | β | 2021 | β |
| PolyTLR7/8a-conjugated, antigen-trapping gold nanorods elicit anticancer immunity against abscopal tumors by photothermal therapy-induced in situ vaccination. | Liu X et al. | β | 2021 | β |
| Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells. | Ogino T et al. | β | 2021 | β |
| Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimens. | Kashima Y et al. | β | 2021 | β |
| Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures. | Suphavilai C et al. | β | 2021 | β |
| Predictive Value of Metabolic Parameters Derived From <sup>18</sup>F-FDG PET/CT for Microsatellite Instability in Patients With Colorectal Carcinoma. | Liu H et al. | β | 2021 | β |
| Preparation of cerium-curcumin and cerium-quercetin complexes and their LEDs irradiation assisted anticancer effects on MDA-MB-231 and A375 cancer cell lines. | Hosseinzadeh R et al. | β | 2021 | β |
| Prognostic value of 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters measured in the primary tumor and suspicious lymph nodes before neoadjuvant therapy in patients with esophageal carcinoma. | Tustumi F et al. | β | 2021 | β |
| Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis. | Shams A et al. | β | 2021 | β |
| Quantifying and controlling bond multivalency for advanced nanoparticle targeting to cells. | Makhani EY et al. | β | 2021 | β |
| Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells. | Lee H et al. | β | 2021 | β |
| SCCLRR: A Robust Computational Method for Accurate Clustering Single Cell RNA-Seq Data. | Zhang W et al. | β | 2021 | β |
| SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells. | Zagorac S et al. | β | 2021 | β |
| Selection of established tumour cells through narrow diameter micropores enriches for elevated Ras/Raf/MEK/ERK MAPK signalling and enhanced tumour growth. | Rudzka DA et al. | β | 2021 | β |
| Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer. | Wu Z et al. | β | 2021 | β |
| Simplified ARCHITECT microfluidic chip through a dual-flip strategy enables stable and versatile tumoroid formation combined with label-free quantitative proteomic analysis. | Feng D et al. | β | 2021 | β |
| Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma. | Haebe S et al. | β | 2021 | β |
| Single-cell RNA sequencing in cancer research. | Zhang Y et al. | β | 2021 | β |
| Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids. | Zhao Y et al. | β | 2021 | β |
| Single-cell transcriptome atlas of human mesenchymal stem cells exploring cellular heterogeneity. | Wang Z et al. | β | 2021 | β |
| Single-Cell Transcriptomic Analysis Revealed a Critical Role of SPP1/CD44-Mediated Crosstalk Between Macrophages and Cancer Cells in Glioma. | He C et al. | β | 2021 | β |
| Single-cell transcriptomics reveal the intratumoral landscape of infiltrated T-cell subpopulations in oral squamous cell carcinoma. | Chen J et al. | β | 2021 | β |
| Smart transformable nanomedicines for cancer therapy. | Wang Y et al. | β | 2021 | β |
| SOX transcription factors and glioma stem cells: Choosing between stemness and differentiation. | Stevanovic M et al. | β | 2021 | β |
| Spatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface. | Hunter MV et al. | β | 2021 | β |
| Spontaneous Fusion of MSC with Breast Cancer Cells Can Generate Tumor Dormancy. | Melzer C et al. | β | 2021 | β |
| Stem cell-based therapy treating glioblastoma multiforme. | Abadi B et al. | β | 2021 | β |
| Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity. | Tu SM et al. | β | 2021 | β |
| Studying leukemia stem cell properties and vulnerabilities with human iPSCs. | Spyrou N et al. | β | 2021 | β |
| Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance. | Li GH et al. | β | 2021 | β |
| Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery. | Nethi SK et al. | β | 2021 | β |
| Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer. | Puranik AD et al. | β | 2021 | β |
| Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier. | Sharma RK et al. | β | 2021 | β |
| Targeting Orphan G Protein-Coupled Receptor 17 with T0 Ligand Impairs Glioblastoma Growth. | Doan P et al. | β | 2021 | β |
| TGFΞ² Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma. | Sato R et al. | β | 2021 | β |
| The Concept of "Cancer Stem Cells" in the Context of Classic Carcinogenesis Hypotheses and Experimental Findings. | Trosko JE | β | 2021 | β |
| The ecology of cancer differentiation therapy. | SolΓ© R et al. | β | 2021 | β |
| The Effect of Oxygen and Micronutrient Composition of Cell Growth Media on Cancer Cell Bioenergetics and Mitochondrial Networks. | Moradi F et al. | β | 2021 | β |
| The epigenetic basis of cellular heterogeneity. | Carter B et al. | β | 2021 | β |
| The Histogram Analysis of Intravoxel Incoherent Motion-Kurtosis Model in the Diagnosis and Grading of Prostate Cancer-A Preliminary Study. | Li C et al. | β | 2021 | β |
| The Identification of Alternative Polyadenylation in Stomach Adenocarcinomas Using the Genotype-Tissue Expression Project and the Cancer Genome Atlas- Stomach Adenocarcinoma Profiles. | Li J et al. | β | 2021 | β |
| The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance. | Patil K et al. | β | 2021 | β |
| Theranostics for Breast Cancer Stem Cells. | Moon WK et al. | β | 2021 | β |
| The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy. | Liu S et al. | β | 2021 | β |
| The Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells. | Jahangiri L et al. | β | 2021 | β |
| Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy. | Hu J et al. | β | 2021 | β |
| Toward uncharted territory of cellular heterogeneity: advances and applications of single-cell RNA-seq. | Lieberman B et al. | β | 2021 | β |
| Translational control of stem cell function. | Saba JA et al. | β | 2021 | β |
| Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology. | Strub T et al. | β | 2021 | β |
| Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer. | Berger K et al. | β | 2021 | β |
| Tumor Heterogeneity and Consequences for Bladder Cancer Treatment. | Lavallee E et al. | β | 2021 | β |
| Ultradense Erythrocyte Bionic Layer Used to Capture Circulating Tumor Cells and Plasma-Assisted High-Purity Release. | Zhang T et al. | β | 2021 | β |
| UPF1 promotes chemoresistance to oxaliplatin through regulation of TOP2A activity and maintenance of stemness in colorectal cancer. | Zhu C et al. | β | 2021 | β |
| When dormancy fuels tumour relapse. | Santos-de-Frutos K et al. | β | 2021 | β |
| Worm-Based Microfluidic Biosensor for Real-Time Assessment of the Metastatic Status. | Zhang J et al. | β | 2021 | β |
| 1,2,3-Triazole tethered 2-mercaptobenzimidazole derivatives: design, synthesis and molecular assessment toward C6 glioma cell line. | Andrade P et al. | β | 2020 | β |
| 3D printed <i>in vitro</i> tumor tissue model of colorectal cancer. | Chen H et al. | β | 2020 | β |
| 90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future. | Horwitz KB et al. | β | 2020 | β |
| A mechanism for epithelial-mesenchymal heterogeneity in a population of cancer cells. | Tripathi S et al. | β | 2020 | β |
| An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity. | Jiang S et al. | β | 2020 | β |
| An integrative ENCODE resource for cancer genomics. | Zhang J et al. | β | 2020 | β |
| A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells. | Lee S et al. | β | 2020 | β |
| A single cell atlas of the human liver tumor microenvironment. | Massalha H et al. | β | 2020 | β |
| Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance. | Ashrafizadeh M et al. | β | 2020 | β |
| Autophagy and cancer: Modulation of cell death pathways and cancer cell adaptations. | Towers CG et al. | β | 2020 | β |
| Beyond finding druggable targets and tumor mutational burden: to measure heterogeneity by ctDNA. | Liu Z et al. | β | 2020 | β |
| Bioinformatics analysis and identification of potential genes related to pathogenesis of cervical intraepithelial neoplasia. | Zhang X et al. | β | 2020 | β |
| Biological Functions and Identification of Novel Biomarker Expressed on the Surface of Breast Cancer-Derived Cancer Stem Cells via Proteomic Analysis. | Koh EY et al. | β | 2020 | β |
| Biomimetic Nanotechnology toward Personalized Vaccines. | Zhou J et al. | β | 2020 | β |
| Cancer cells stemness: A doorstep to targeted therapy. | Prasad S et al. | β | 2020 | β |
| Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets. | Park JH et al. | β | 2020 | β |
| Cancer stem cell plasticity in glioblastoma multiforme: a perspective on future directions in oncolytic virotherapy. | Kim DS | β | 2020 | β |
| Cancer Stem Cells and Combination Therapies to Eradicate Them. | Tang Q et al. | β | 2020 | β |
| Cancer stem cells and their niche in the progression of squamous cell carcinoma. | Oshimori N | β | 2020 | β |
| Cellular plasticity and drug resistance in sarcoma. | Lin Z et al. | β | 2020 | β |
| Clinical implications of intratumor heterogeneity: challenges and opportunities. | RamΓ³n Y Cajal S et al. | β | 2020 | β |
| Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment. | Jahanafrooz Z et al. | β | 2020 | β |
| Complete regression of metastatic de-differentiated liposarcoma with engineered mesenchymal stromal cells with dTRAIL and HSV-TK. | Jo EB et al. | β | 2020 | β |
| Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype. | Qin N et al. | β | 2020 | β |
| Convergent Evolution, Evolving Evolvability, and the Origins of Lethal Cancer. | Pienta KJ et al. | β | 2020 | β |
| Covalent Organic Framework-Based Nanocomposite for Synergetic Photo-, Chemodynamic-, and Immunotherapies. | Liu S et al. | β | 2020 | β |
| CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer. | Olivares-Urbano MA et al. | β | 2020 | β |
| Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents. | Wu LQ et al. | β | 2020 | β |
| Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs. | El Mansouri AE et al. | β | 2020 | β |
| Detecting heterogeneity in and between breast cancer cell lines. | Shen Y et al. | β | 2020 | β |
| Deterministic culturing of single cells in 3D. | Jain R et al. | β | 2020 | β |
| Different Camptothecin Sensitivities in Subpopulations of Colon Cancer Cells Correlate with Expression of Different Phospho-Isoforms of Topoisomerase I with Different Activities. | Tesauro C et al. | β | 2020 | β |
| Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy. | Jiang L et al. | β | 2020 | β |
| Drug Conjugates Using Different Dynamic Covalent Bonds and their Application in Cancer Therapy. | Theodosis-Nobelos P et al. | β | 2020 | β |
| Drug Resistance in Non-Hodgkin Lymphomas. | Klener P et al. | β | 2020 | β |
| Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma. | Krook MA et al. | β | 2020 | β |
| Emerging role of tumor cell plasticity in modifying therapeutic response. | Qin S et al. | β | 2020 | β |
| Engineering Prostate Cancer from Induced Pluripotent Stem Cells-New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies. | Hepburn AC et al. | β | 2020 | β |
| Epigenetic plasticity in metastatic dormancy: mechanisms and therapeutic implications. | Robinson NJ et al. | β | 2020 | β |
| Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype. | Xu T et al. | β | 2020 | β |
| Exploiting evolutionary steering to induce collateral drug sensitivity in cancer. | Acar A et al. | β | 2020 | β |
| Extracellular Vesicles as Drug Delivery Systems in Cancer. | Hernandez-Oller L et al. | β | 2020 | β |
| Fibroblasts-dependent invasion of podoplanin-positive cancer stem cells in squamous cell carcinoma. | Miyashita T et al. | β | 2020 | β |
| Fluorescent Polysaccharide Nanogels for the Detection of Tumor Heterogeneity in Drug-Surviving Cancer Cells. | Wang C et al. | β | 2020 | β |
| Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin. | Busico A et al. | β | 2020 | β |
| Geometric regulation of histone state directs melanoma reprogramming. | Lee J et al. | β | 2020 | β |
| HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model. | Stockhammer P et al. | β | 2020 | β |
| High expression of KrΓΌppel-like factor 5 is associated with poor prognosis in patients with colorectal cancer. | Takagi Y et al. | β | 2020 | β |
| How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects. | Tabor S et al. | β | 2020 | β |
| Hydrodynamic shear-based purification of cancer cells with enhanced tumorigenic potential. | CermeΓ±o EA et al. | β | 2020 | β |
| Hypoxic colorectal cancer cells promote metastasis of normoxic cancer cells depending on IL-8/p65 signaling pathway. | Mi Y et al. | β | 2020 | β |
| Identifying Cell-Type Specific Genes and Expression Rules Based on Single-Cell Transcriptomic Atlas Data. | Yuan F et al. | β | 2020 | β |
| Imidazo[1,2-<i>a</i>]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells. | Quattrini L et al. | β | 2020 | β |
| Immunohistochemical BRAF V600E Expression and Intratumor BRAF V600E Heterogeneity in Acral Melanoma: Implication in Melanoma-Specific Survival. | Ito T et al. | β | 2020 | β |
| Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness. | Hass R et al. | β | 2020 | β |
| Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy. | Baram T et al. | β | 2020 | β |
| Insights into new mechanisms and models of cancer stem cell multidrug resistance. | Garcia-Mayea Y et al. | β | 2020 | β |
| In Silico implementation of evolutionary paradigm in therapy design: Towards anti-cancer therapy as Darwinian process. | Brutovsky B et al. | β | 2020 | β |
| Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies. | Tanabe S et al. | β | 2020 | β |
| Intracellular Ca<sup>2 +</sup> Imbalance Critically Contributes to Paraptosis. | Kim E et al. | β | 2020 | β |
| Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies. | Zhang Q et al. | β | 2020 | β |
| Investigating Tumor Heterogeneity in Mouse Models. | Tammela T et al. | β | 2020 | β |
| In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo. | Parayath NN et al. | β | 2020 | β |
| LAMP: disease classification derived from layered assessment on modules and pathways in the human gene network. | Mi Z et al. | β | 2020 | β |
| Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia. | Villatoro A et al. | β | 2020 | β |
| Lipidome-based rapid diagnosis with machine learning for detection of TGF-Ξ² signalling activated area in head and neck cancer. | Ishii H et al. | β | 2020 | β |
| Lipidomic profiling of single mammalian cells by infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI). | Xi Y et al. | β | 2020 | β |
| Magnetic resonance imaging features for predicting axillary lymph node metastasis in patients with breast cancer. | Zhao M et al. | β | 2020 | β |
| Matrix stiffness-sensitive long noncoding RNA NEAT1 seeded paraspeckles in cancer cells. | Todorovski V et al. | β | 2020 | β |
| Mechanistic Pharmacokinetic/Pharmacodynamic Model of Sunitinib and Dopamine in MCF-7/Adr Xenografts: Linking Cellular Heterogeneity to Tumour Burden. | Wang S et al. | β | 2020 | β |
| Metabolic Adaptations in Cancer Stem Cells. | Yadav UP et al. | β | 2020 | β |
| Metabolic reprogramming and disease progression in cancer patients. | Torresano L et al. | β | 2020 | β |
| Metabolic reprogramming in cancer: the bridge that connects intracellular stresses and cancer behaviors. | Zhou Y et al. | β | 2020 | β |
| Microfluidic Platform for the Isolation of Cancer-Cell Subpopulations Based on Single-Cell Glycolysis. | Zielke C et al. | β | 2020 | β |
| Minimal barriers to invasion during human colorectal tumor growth. | Ryser MD et al. | β | 2020 | β |
| Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma. | Aminuddin A et al. | β | 2020 | β |
| Modeling cancer progression using human pluripotent stem cell-derived cells and organoids. | Zhang M et al. | β | 2020 | β |
| Morphology, Motility, and Cytoskeletal Architecture of Breast Cancer Cells Depend on Keratin 19 and Substrate. | Lam VK et al. | β | 2020 | β |
| Multiplex Stimulated Raman Scattering Imaging Cytometry Reveals Lipid-Rich Protrusions in Cancer Cells under Stress Condition. | Huang KC et al. | β | 2020 | β |
| New addiction to the NRF2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome. | Kobayashi A et al. | β | 2020 | β |
| Novel Therapeutic Strategies for Ovarian Cancer Stem Cells. | Terraneo N et al. | β | 2020 | β |
| Origin recognition complex subunit 1 regulates cell growth and metastasis in glioma by altering activation of ERK and JNK signaling pathway. | Xiong W et al. | β | 2020 | β |
| Paclitaxel and Sorafenib: The Effective Combination of Suppressing the Self-Renewal of Cancer Stem Cells. | Nawara HM et al. | β | 2020 | β |
| Pan-cancer analysis of the metabolic reaction network. | Gatto F et al. | β | 2020 | β |
| PAWI-2 overcomes tumor stemness and drug resistance via cell cycle arrest in integrin Ξ²<sub>3</sub>-KRAS-dependent pancreatic cancer stem cells. | Cheng J et al. | β | 2020 | β |
| PD-L1 expression in liver metastasis: its clinical significance and discordance with primary tumor in colorectal cancer. | Wei XL et al. | β | 2020 | β |
| Periplocin mediates TRAIL-induced apoptosis and cell cycle arrest in human myxofibrosarcoma cells via the ERK/p38/JNK pathway. | Lohberger B et al. | β | 2020 | β |
| Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity. | Nijman SMB | β | 2020 | β |
| Phospholipase D and Choline Metabolism. | Onono FO et al. | β | 2020 | β |
| Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. | Fumagalli A et al. | β | 2020 | β |
| PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer. | Igarashi H et al. | β | 2020 | β |
| Preserving Single Cells in Space and Time for Analytical Assays. | Gallion LA et al. | β | 2020 | β |
| Prognostic impact of intra-field heterogeneity in oral squamous cell carcinoma. | Gabusi A et al. | β | 2020 | β |
| Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization. | Fanelli GN et al. | β | 2020 | β |
| Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review. | Indoria S et al. | β | 2020 | β |
| Role of CD133 in human embryonic stem cell proliferation and teratoma formation. | Wang H et al. | β | 2020 | β |
| Role of imaging biomarkers for prognostic prediction in patients with pancreatic ductal adenocarcinoma. | Cui SJ et al. | β | 2020 | β |
| RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells. | Fritz AJ et al. | β | 2020 | β |
| Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity. | Vernot JP | β | 2020 | β |
| Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets. | De A et al. | β | 2020 | β |
| Shortwave-infrared meso-patterned imaging enables label-free mapping of tissue water and lipid content. | Zhao Y et al. | β | 2020 | β |
| Silicon Photomultipliers as a Low-Cost Fluorescence Detector for Capillary Electrophoresis. | Petersen BV et al. | β | 2020 | β |
| Single-cell-level screening method for migratory cancer cells and its potential feasibility in high-throughput manner. | Shen Q et al. | β | 2020 | β |
| Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. | Couturier CP et al. | β | 2020 | β |
| Strategies for Cancer Immunotherapy Using Induced Pluripotency Stem Cells-Based Vaccines. | Bernardes de Jesus B et al. | β | 2020 | β |
| Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion. | Commander R et al. | β | 2020 | β |
| Synthesis and initial screening of lactate dehydrogenase inhibitor activity of 1,3-benzodioxole derivatives. | Annas D et al. | β | 2020 | β |
| Systems-Level Properties of EGFR-RAS-ERK Signaling Amplify Local Signals to Generate Dynamic Gene Expression Heterogeneity. | Davies AE et al. | β | 2020 | β |
| Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI. | Taghizadeh H et al. | β | 2020 | β |
| Targeting of cancer stem cells by differentiation therapy. | Arima Y et al. | β | 2020 | β |
| Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age. | Ferreira R et al. | β | 2020 | β |
| Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors. | Confeld MI et al. | β | 2020 | β |
| TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy. | Xu Z et al. | β | 2020 | β |
| The evolution of resistance and tolerance as cancer defences. | Thomas F et al. | β | 2020 | β |
| The genomic landscape of metastasis in treatment-naΓ―ve breast cancer models. | Ross C et al. | β | 2020 | β |
| The Intimate Relationship Among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes. | Hass R et al. | β | 2020 | β |
| The Metabolic Heterogeneity and Flexibility of Cancer Stem Cells. | Tanabe A et al. | β | 2020 | β |
| The pseudogene problem and RT-qPCR data normalization; SYMPK: a suitable reference gene for papillary thyroid carcinoma. | Javadirad SM et al. | β | 2020 | β |
| Therapy Response and Outcome Explained by Leukemia Cell of Origin. | Gu Z et al. | β | 2020 | β |
| The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma. | Vora P et al. | β | 2020 | β |
| The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells. | Hu Z et al. | β | 2020 | β |
| The Role of Cancer Stem Cells in Radiation Resistance. | Arnold CR et al. | β | 2020 | β |
| The Role of MYCN in Symmetric vs. Asymmetric Cell Division of Human Neuroblastoma Cells. | Izumi H et al. | β | 2020 | β |
| The role of TRPV1 ion channels in the suppression of gastric cancer development. | Gao N et al. | β | 2020 | β |
| The Stress-Like Cancer Cell State Is a Consistent Component of Tumorigenesis. | Baron M et al. | β | 2020 | β |
| Transcriptional information underlying the generation of CSCs and the construction of a nine-mRNA signature to improve prognosis prediction in colorectal cancer. | Zheng W et al. | β | 2020 | β |
| Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer. | Wang R et al. | β | 2020 | β |
| Triangular correlation (TrC) between cancer aggressiveness, cell uptake capability, and cell deformability. | Brill-Karniely Y et al. | β | 2020 | β |
| Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1. | Lee YH et al. | β | 2020 | β |
| Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer | Cao S et al. | β | 2020 | β |
| Tumor Innervation: Cancer Has Some Nerve. | Reavis HD et al. | β | 2020 | β |
| Tumor microenvironment differences between primary tumor and brain metastases. | Cacho-DΓaz B et al. | β | 2020 | β |
| Ultrasound in tumor immunotherapy: Current status and future developments. | Ho YJ et al. | β | 2020 | β |
| Understanding of tumourigenesis in canine mammary tumours based on cancer stem cell research. | Michishita M | β | 2020 | β |
| Unraveling cancer lineage drivers in squamous cell carcinomas. | Guan Y et al. | β | 2020 | β |
| Using medical claims database to develop a population disease progression model for leuprorelin-treated subjects with hormone-sensitive prostate cancer. | Zou Y et al. | β | 2020 | β |
| Whole-exome mutational landscape of metastasis in patient-derived hepatocellular carcinoma cells. | Zhou Q et al. | β | 2020 | β |
| Wnt/Ξ²-catenin-activated Ewing sarcoma cells promote the angiogenic switch. | Hawkins AG et al. | β | 2020 | β |
| A Case of Identity: <i>HOX</i> Genes in Normal and Cancer Stem Cells. | Smith J et al. | β | 2019 | β |
| A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents. | Antoszczak M | β | 2019 | β |
| Acquisition of temozolomide resistance by the rat C6 glioma cell line increases cell migration and side population phenotype. | Xu Y et al. | β | 2019 | β |
| Adipocytes sensitize melanoma cells to environmental TGF-Ξ² cues by repressing the expression of miR-211. | Golan T et al. | β | 2019 | β |
| A Framework Linking Glycolytic Metabolic Capabilities and Tumor Dynamics. | Tzamali E et al. | β | 2019 | β |
| A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting Drugs. | Belur Nagaraj A et al. | β | 2019 | β |
| A new model isolates glioblastoma clonal interactions and reveals unexpected modes for regulating motility, proliferation, and drug resistance. | Davis JB et al. | β | 2019 | β |
| An integrated cell printing system for the construction of heterogeneous tissue models. | Liu TK et al. | β | 2019 | β |
| A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells. | Orienti I et al. | β | 2019 | β |
| A novel pan-cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic. | Liu W et al. | β | 2019 | β |
| Application value of CyTOF 2 mass cytometer technology at single-cell level in human gastric cancer cells. | Han S et al. | β | 2019 | β |
| Aptamers as the chaperones (Aptachaperones) of drugs-from siRNAs to DNA nanorobots. | Citartan M et al. | β | 2019 | β |
| ASB6 Promotes the Stemness Properties and Sustains Metastatic Potential of Oral Squamous Cell Carcinoma Cells by Attenuating ER Stress. | Hung KF et al. | β | 2019 | β |
| A sequential Monte Carlo algorithm for inference of subclonal structure in cancer. | Ogundijo OE et al. | β | 2019 | β |
| A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors. | Liu M et al. | β | 2019 | β |
| A Soft Matrix Enhances the Cancer Stem Cell Phenotype of HCC Cells. | Tian B et al. | β | 2019 | β |
| Aspirin enhances cisplatin sensitivity of resistant non-small cell lung carcinoma stem-like cells by targeting mTOR-Akt axis to repress migration. | Khan P et al. | β | 2019 | β |
| Autophagy, cancer stem cells and drug resistance. | Smith AG et al. | β | 2019 | β |
| Baicalein Suppresses Stem Cell-Like Characteristics in Radio- and Chemoresistant MDA-MB-231 Human Breast Cancer Cells through Up-Regulation of IFIT2. | Koh SY et al. | β | 2019 | β |
| Bioactive lipids in cancer stem cells. | Begicevic RR et al. | β | 2019 | β |
| Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma. | Lin L et al. | β | 2019 | β |
| Brain Tumors of Glial Origin. | Waker CA et al. | β | 2019 | β |
| Breast Tumor Detection and Classification Using Intravoxel Incoherent Motion Hyperspectral Imaging Techniques. | Chan SW et al. | β | 2019 | β |
| Cancer-associated fibroblasts in gastrointestinal cancer. | Kobayashi H et al. | β | 2019 | β |
| Cancer cell reprogramming: a promising therapy converting malignancy to benignity. | Gong L et al. | β | 2019 | β |
| CancerSEA: a cancer single-cell state atlas. | Yuan H et al. | β | 2019 | β |
| Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects. | Yadav AK et al. | β | 2019 | β |
| Cancer stem cells in breast and prostate: Fact or fiction? | Sampayo RG et al. | β | 2019 | β |
| CAR T cells for brain tumors: Lessons learned and road ahead. | Akhavan D et al. | β | 2019 | β |
| CD44v6 engages in colorectal cancer progression. | Ma L et al. | β | 2019 | β |
| Cell population heterogeneity driven by stochastic partition and growth optimality. | Fernandez-de-Cossio-Diaz J et al. | β | 2019 | β |
| Cellular Plasticity in Cancer. | Yuan S et al. | β | 2019 | β |
| Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles. | Gao J et al. | β | 2019 | β |
| Computational modelling of resistance and associated treatment response heterogeneity in metastatic cancers. | Turk M et al. | β | 2019 | β |
| Context-Dependent Role of NF-ΞΊB Signaling in Primary Liver Cancer-from Tumor Development to Therapeutic Implications. | Czauderna C et al. | β | 2019 | β |
| Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity. | Yang XG et al. | β | 2019 | β |
| Cutting Off Leukemogenesis: Hydra-like Plasticity of Mature Leukemic Cells. | Bamezai S et al. | β | 2019 | β |
| Dean Flow Assisted Single Cell and Bead Encapsulation for High Performance Single Cell Expression Profiling. | Li L et al. | β | 2019 | β |
| Deep learning with evolutionary and genomic profiles for identifying cancer subtypes. | Lin CY et al. | β | 2019 | β |
| De Novo PITX1 Expression Controls Bi-Stable Transcriptional Circuits to Govern Self-Renewal and Differentiation in Squamous Cell Carcinoma. | Sastre-Perona A et al. | β | 2019 | β |
| Designing a nanoparticle-containing polymeric substrate for detecting cancer cells by computer simulations. | Huang LY et al. | β | 2019 | β |
| DNA Damage Signaling-Induced Cancer Cell Reprogramming as a Driver of Tumor Relapse. | Filipponi D et al. | β | 2019 | β |
| DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells. | Visone R et al. | β | 2019 | β |
| Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine). | De Francesco EM et al. | β | 2019 | β |
| Dynamics of Minimal Residual Disease in Neuroblastoma Patients. | Uemura S et al. | β | 2019 | β |
| Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells. | Nasr MA et al. | β | 2019 | β |
| EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells. | Rodriguez-Aznar E et al. | β | 2019 | β |
| Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma. | Farid RM et al. | β | 2019 | β |
| Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center. | Lee K et al. | β | 2019 | β |
| Glucocorticoids promote breast cancer metastasis. | ObradoviΔ MMS et al. | β | 2019 | β |
| Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs). | Sotgia F et al. | β | 2019 | β |
| Heterogeneity Diffusion Imaging of gliomas: Initial experience and validation. | Wang Q et al. | β | 2019 | β |
| High-throughput, label-free, single-cell photoacoustic microscopy of intratumoral metabolic heterogeneity. | Hai P et al. | β | 2019 | β |
| <i>BRCA</i> Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance. | Gorodetska I et al. | β | 2019 | β |
| Identification of side arm-modified DOTA scaffolds as multi-site binding ligands for cancer cells over normal cells. | Rustagi V et al. | β | 2019 | β |
| Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors. | Roca MS et al. | β | 2019 | β |
| Inβ Situ Self-Assembled Nanofibers Precisely Target Cancer-Associated Fibroblasts for Improved Tumor Imaging. | Zhao XX et al. | β | 2019 | β |
| Integrating Clinical and Genetic Analysis of Perineural Invasion in Head and Neck Squamous Cell Carcinoma. | Zhang Z et al. | β | 2019 | β |
| Integrin Ξ±6 (CD49f), The Microenvironment and Cancer Stem Cells. | Bigoni-OrdΓ³Γ±ez GD et al. | β | 2019 | β |
| Intra- and Inter-Tumor <i>BRAF</i> Heterogeneity in Acral Melanoma: An Immunohistochemical Analysis. | Ito T et al. | β | 2019 | β |
| In vivo study of gene expression with an enhanced dual-color fluorescent transcriptional timer. | He L et al. | β | 2019 | β |
| Iron Metabolism in Liver Cancer Stem Cells. | Recalcati S et al. | β | 2019 | β |
| Issues and opportunities of stem cell therapy in autoimmune diseases. | MΕ±zes G et al. | β | 2019 | β |
| LATS1/2 kinases trigger self-renewal of cancer stem cells in aggressive oral cancer. | Nozaki M et al. | β | 2019 | β |
| Leukemia Stem Cells in the Pathogenesis, Progression, and Treatment of Acute Myeloid Leukemia. | Joshi K et al. | β | 2019 | β |
| Live sperm trap microarray for high throughput imaging and analysis. | You JB et al. | β | 2019 | β |
| LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling. | Wang Y et al. | β | 2019 | β |
| Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention. | Khoo BL et al. | β | 2019 | β |
| Methionine is a metabolic dependency of tumor-initiating cells. | Wang Z et al. | β | 2019 | β |
| MicroRNA-A Tumor Trojan Horse for Tumor-Associated Macrophages. | Syed SN et al. | β | 2019 | β |
| Migration through physical constraints is enabled by MAPK-induced cell softening via actin cytoskeleton re-organization. | Rudzka DA et al. | β | 2019 | β |
| Modeling differentiation-state transitions linked to therapeutic escape in triple-negative breast cancer. | Chapman MP et al. | β | 2019 | β |
| Modeling heterogeneous tumor growth dynamics and cell-cell interactions at single-cell and cell-population resolution. | Harris LA et al. | β | 2019 | β |
| Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. | Genitsch V et al. | β | 2019 | β |
| Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer. | Genitsch V et al. | β | 2019 | β |
| Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas. | Long Y et al. | β | 2019 | β |
| Multiplexed, Sequential Secretion Analysis of the Same Single Cells Reveals Distinct Effector Response Dynamics Dependent on the Initial Basal State. | Chen Z et al. | β | 2019 | β |
| Multiplexed Single-Cell Measurements of FDG Uptake and Lactate Release Using Droplet Microfluidics. | Sengupta D et al. | β | 2019 | β |
| Multiplex live single-cell transcriptional analysis demarcates cellular functional heterogeneity. | Atmanli A et al. | β | 2019 | β |
| Next Generation Networks: Featuring the Potential Role of Emerging Applications in Translational Oncology. | Capobianco E | β | 2019 | β |
| Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985). | Xu Z et al. | β | 2019 | β |
| Novel insights into the role of aptamers in the fight against cancer. | Maimaitiyiming Y et al. | β | 2019 | β |
| Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways. | Das PK et al. | β | 2019 | β |
| Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells. | Vengoji R et al. | β | 2019 | β |
| NOX1-Dependent mTORC1 Activation via S100A9 Oxidation in Cancer Stem-like Cells Leads to Colon Cancer Progression. | Ohata H et al. | β | 2019 | β |
| Ovarian Teratoid Carcinosarcoma Is an Aggressive Tumor of Probable Mullerian Derivation with a Carcinosarcomatous and Mixed Germ-Cell Morphology. | Fox C et al. | β | 2019 | β |
| Pan-Cancer and Single-Cell Modeling of Genomic Alterations Through Gene Expression. | Mercatelli D et al. | β | 2019 | β |
| Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis. | Rokavec M et al. | β | 2019 | β |
| Parallel Analyses of Somatic Mutations in Plasma Circulating Tumor DNA (ctDNA) and Matched Tumor Tissues in Early-Stage Breast Cancer. | Zhang X et al. | β | 2019 | β |
| Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. | Minata M et al. | β | 2019 | β |
| Recent advances in single cell manipulation and biochemical analysis on microfluidics. | Gao D et al. | β | 2019 | β |
| Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery. | Zhang Y et al. | β | 2019 | β |
| Reprogramming of cancer stem cells into non-tumorigenic cells using stem cell exosomes for cancer therapy. | Lee KS et al. | β | 2019 | β |
| Review on biofabrication and applications of heterogeneous tumor models. | Liu T et al. | β | 2019 | β |
| RNA modifications regulating cell fate in cancer. | Delaunay S et al. | β | 2019 | β |
| Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. | Wu HJ et al. | β | 2019 | β |
| Sensing of circulating cancer biomarkers with metal nanoparticles. | Pallares RM et al. | β | 2019 | β |
| Sensor Array Fabricated with Nanoscale Metal-Organic Frameworks for the Histopathological Examination of Colon Cancer. | Wu S et al. | β | 2019 | β |
| SeqClone: sequential Monte Carlo based inference of tumor subclones. | Ogundijo OE et al. | β | 2019 | β |
| SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence. | Ye S et al. | β | 2019 | β |
| Single-Cell DNA-Seq and RNA-Seq in Cancer Using the C1 System. | Seki M et al. | β | 2019 | β |
| Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells. | Zhao Y et al. | β | 2019 | β |
| SOD2 acetylation and deacetylation: Another tale of Jekyll and Hyde in cancer. | Hjelmeland AB et al. | β | 2019 | β |
| Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target. | Ma XL et al. | β | 2019 | β |
| Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. | Dirkse A et al. | β | 2019 | β |
| Stochastic modeling of phenotypic switching and chemoresistance in cancer cell populations. | Kumar N et al. | β | 2019 | β |
| Supramolecular nanoassembly of lysozyme and Ξ±-lactalbumin (apo Ξ±-LA) exhibits selective cytotoxicity and enhanced bioavailability of curcumin to cancer cells. | Somu P et al. | β | 2019 | β |
| Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer. | Ehrenberg KR et al. | β | 2019 | β |
| Systems biology: perspectives on multiscale modeling in research on endocrine-related cancers. | Clarke R et al. | β | 2019 | β |
| Telomere Maintenance-Associated PML Is a Potential Specific Therapeutic Target of Human Colorectal Cancer. | Gong P et al. | β | 2019 | β |
| The Application of Nanotechnology in the Codelivery of Active Constituents of Plants and Chemotherapeutics for Overcoming Physiological Barriers during Antitumor Treatment. | Li Q et al. | β | 2019 | β |
| The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations. | Sugimori M et al. | β | 2019 | β |
| The CTLH Complex in Cancer Cell Plasticity. | Huffman N et al. | β | 2019 | β |
| The Exosome And Breast Cancer Cell Plasticity. | Mao X et al. | β | 2019 | β |
| The invasion of de-differentiating cancer cells into hierarchical tissues. | Zhou D et al. | β | 2019 | β |
| The kidney transcriptome, from single cells to whole organs and back. | Huang S et al. | β | 2019 | β |
| The nanoparticle-facilitated autophagy inhibition of cancer stem cells for improved chemotherapeutic effects on glioblastomas. | Lu L et al. | β | 2019 | β |
| Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment. | Sun HR et al. | β | 2019 | β |
| Therapeutic targeting of gastrointestinal cancer stem cells. | Stem J et al. | β | 2019 | β |
| The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance. | Beltran H et al. | β | 2019 | β |
| The role of proteases in epithelial-to-mesenchymal cell transitions in cancer. | Mitschke J et al. | β | 2019 | β |
| The Tumor Suppressor Role of Zinc Finger Protein 671 (<i>ZNF671</i>) in Multiple Tumors Based on Cancer Single-Cell Sequencing. | Zhang J et al. | β | 2019 | β |
| Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems. | Khondakar KR et al. | β | 2019 | β |
| Towards the Delivery of Precision Veterinary Cancer Medicine. | Katogiritis A et al. | β | 2019 | β |
| Toxicity and Antitumor Activity of a Thiophene-Acridine Hybrid. | Lisboa T et al. | β | 2019 | β |
| Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles. | Voglstaetter M et al. | β | 2019 | β |
| Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy. | Krook MA et al. | β | 2019 | β |
| Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response. | Lorenzo-Sanz L et al. | β | 2019 | β |
| VEGF/Neuropilin Signaling in Cancer Stem Cells. | Mercurio AM | β | 2019 | β |
| Visualizing RNA dynamics in live cells with bright and stable fluorescent RNAs. | Chen X et al. | β | 2019 | β |
| WNT Signaling in Tumors: The Way to Evade Drugs and Immunity. | Martin-Orozco E et al. | β | 2019 | β |
| "Energetic" Cancer Stem Cells (e-CSCs): A New Hyper-Metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy. | Fiorillo M et al. | β | 2018 | β |
| Identification of cancer subtypes from single-cell RNA-seq data using a consensus clustering method. | Gan Y et al. | β | 2018 | β |
| Therapeutic Cancer Vaccines-T Cell Responses and Epigenetic Modulation. | Kartikasari AER et al. | β | 2018 | β |